Alabama Health Officials Urge Protection from Mosquito and Tick Bites
The Alabama Department of Public Health (ADPH) issued a notice reminding residents to protect themselves from mosquito and tick bites due to the risk of vector-borne diseases like West Nile virus and Lyme disease. The notice provides recommendations for preventing bites, including using insect repellent, wearing protective clothing, and eliminating standing water.
BEIJING 2022 Trademark Application Includes Medical Monitoring Equipment
The USPTO has recorded a trademark application for 'BEIJING 2022' that includes medical monitoring equipment among its listed goods and services. This trademark application covers a broad range of items, including computer software for patient monitoring and data collection involving vital medical signs.
Diligent Robotics Trademark Application - Service Robots
The USPTO has processed a trademark application for Diligent Robotics concerning commercial service robots and medical service robots. The application covers robots designed for assistance and information in various environments, including hospitals, retail, and hotels.
Theralight electronic light therapy apparatus trademark registered
The United States Patent and Trademark Office has registered the trademark 'Theralight' for electronic light therapy apparatus for the skin. The trademark was registered on March 26, 2026, under application number TM86880788, following a filing date of January 20, 2016.
Xeryon Medical Instruments Trademark Application Published
The USPTO has published the trademark application for Xeryon, covering piezoelectric apparatus and instruments for medical, scientific, and industrial use. The application was filed on November 19, 2025, and published for opposition on March 26, 2026.
Fits Compression trademark application for medical socks
The USPTO has received an intent-to-use trademark application for 'Fits Compression' for medical or therapeutic socks. The application was filed on March 25, 2019, and is designated for Class 010, which covers medical devices.
ASPARGO Trademark Application for Medical Instruments and Drug Delivery Devices
The USPTO has received an intent-to-use trademark application (TM90455390) for the mark ASPARGO. The application covers medical instruments, drug delivery devices, and pharmaceuticals, including sildenafil for erectile dysfunction treatment.
Flowonix Registered Trademark for Medical Devices
The USPTO has registered the trademark 'Flowonix' for a range of medical devices, including implantable infusion pumps, catheters, and related kits. The trademark was registered on March 26, 2026, following a filing date of July 27, 2011.
TURBOWAVE Trademark Published for Opposition
The USPTO has published the TURBOWAVE trademark application for opposition. The application covers microwave analysis apparatus, including those for medical purposes. The publication date is March 26, 2026, with a filing date of November 5, 2025.
Biolox Material Matters Trademark for Surgical Instruments
The USPTO has published the trademark application 'Biolox Material Matters' for goods including artificial implants, surgical instruments, and materials for osteosynthesis. The application was filed on September 30, 2025, and published for opposition on March 26, 2026.
LIFT 2 GLOW Medical Device Trademark Published for Opposition
The USPTO has published the trademark application for 'LIFT 2 GLOW' for medical devices, including lasers and ultrasonic apparatus, for opposition. The application was filed on September 25, 2025, and published on March 26, 2026.
NEXELLO Medical Instruments Trademark Publication
The USPTO published the trademark application for NEXELLO, covering orthopaedic articles, prostheses, and medical footwear. The application was published for opposition on March 26, 2026, with a filing date of October 9, 2025.
Pocket Physio trademark published for therapeutic massage instruments
The USPTO has published the trademark application for 'Pocket Physio' for therapeutic massage instruments. The application, filed on September 2, 2025, covers a range of electrically operated and portable massage devices intended for muscle relaxation and physiotherapy.
Kawasumi Laboratories Medical Instruments Trademark Registration
The United States Patent and Trademark Office has registered trademark application TM74434946 for Kawasumi Laboratories, covering various medical apparatus and instruments. The registration was finalized on March 26, 2026, following a filing date of September 13, 1993.
Kronner Manipujector Trademark Registration
The USPTO has registered the trademark 'Kronner Manipujector' for a uterine manipulator and injector. The trademark was filed on November 20, 1992, and registered on March 26, 2026.
IXCLERMA Trademark Published for Opposition
The USPTO has published the trademark application for IXCLERMA for opposition. The application covers pharmaceutical preparations for the treatment of various medical conditions, including arthritis, spondylitis, psoriasis, and autoimmune diseases.
Kizefma Trademark Published for Opposition
The USPTO has published the trademark application for 'Kizefma' for opposition. The application covers various medical and pharmaceutical uses, including treatments for arthritis, spondylitis, psoriasis, and autoimmune diseases. The filing date was October 16, 2025.
WECHECK trademark application published for diagnostic reagents
The USPTO published the trademark application for 'WECHECK' on March 26, 2026. The application covers diagnostic reagents and test strips for medical purposes, including blood glucose monitoring. This publication opens a period for opposition before the trademark is granted.
CILIATECH trademark application published for opposition
The USPTO has published the trademark application for CILIATECH, which covers a range of goods and services related to ophthalmology, including medical research, prostheses, implants, and pharmaceutical products. The application was published for opposition on March 26, 2026.
VITBLISS Trademark Application Published for Opposition
The USPTO has published the trademark application for VITBLISS, filed on October 2, 2025, for opposition. The application covers dietary supplements and dietetic preparations. The publication date is March 26, 2026.
YUMIVET Trademark Publication for Opposition
The USPTO has published the YUMIVET trademark application for opposition. The application, filed on November 19, 2025, covers veterinary products and chemical preparations for medical use. The publication date for opposition is March 26, 2026.
Bruker Mbioseq Trademark Application Published for Opposition
The USPTO has published the trademark application for 'Bruker Mbioseq' for opposition. The application covers reagents, assays, and software related to medical diagnostics, molecular biology, and laboratory apparatus. The filing date was November 18, 2025.
TIRAMAZ Trademark Application Published
The USPTO has published the trademark application for TIRAMAZ, filed on September 29, 2025. The application covers chemicals for industrial, agricultural, horticultural, and forestry use, including fertilizers, biostimulants, and plant growth regulators. This publication marks a step in the trademark registration process.
MBIOSEQ Trademark Application Published for Opposition
The USPTO has published the trademark application for MBIOSEQ for opposition. The application covers reagents, assays, software, and instruments related to medical diagnostics, molecular biology, and laboratory testing. The filing date was November 18, 2025.
FREEMOVERS trademark published for opposition
The USPTO has published the FREEMOVERS trademark application for opposition. The application, filed on November 18, 2025, covers babies' diapers and diaper-pants. The publication date for opposition is March 26, 2026.
POKéMON Trademark Application TM79436893 Published
The USPTO published trademark application TM79436893 for POKéMON, covering a wide range of goods including clothing, electronics, food supplements, pet supplies, and digital media. The publication marks the beginning of the opposition period for this application.
RXILIENT Trademark Application Published for Opposition
The USPTO has published the trademark application for 'RXILIENT' for pharmaceutical products, initiating a 30-day opposition period. The application, filed on November 19, 2025, covers a wide range of pharmaceutical preparations and dermatological products.
MAGNFIX trademark published for opposition
The USPTO has published the MAGNFIX trademark for opposition. The application covers a range of products including biocides, fungicides, disinfectants, and agricultural preparations for seed treatment and crop protection. The filing date was October 2, 2025.
MEILUX Trademark Published for Opposition
The USPTO has published the MEILUX trademark for opposition, covering a range of pharmaceutical and cosmetic products. The application was filed on November 19, 2025, and published for opposition on March 26, 2026.
KIZELMY Trademark Application Published for Opposition
The USPTO has published the KIZELMY trademark application for opposition. The application, filed on October 16, 2025, covers pharmaceutical preparations for treating various medical conditions. The publication opens a period for third parties to oppose the trademark registration.
VALALTO Trademark Application Published for Opposition
The USPTO has published the VALALTO trademark application for opposition. The application covers a wide range of goods and services, including pharmaceuticals, dietetic foods, and retail services related to these products. The publication initiates a period during which third parties may oppose the registration of the mark.
FARCO trademark published for opposition
The USPTO has published the FARCO trademark application for opposition. The application covers pharmaceutical preparations for use in urology and sanitary preparations for medical purposes. The publication date was March 26, 2026.
Trademark 79441140 Published for Opposition
The USPTO has published trademark application 79441140 for opposition. The application covers a wide range of food products, including flour, cereals, confectionery, noodles, and baby food, as well as dietary supplements and preparations for medical use. The filing date for this application was November 18, 2025.
SECRETECH Trademark Publication for Opposition
The USPTO has published the SECRETECH trademark application (TM79437413) for opposition. The application covers a range of goods and services including diagnostic reagents, sterilizing preparations, nutraceuticals, and scientific research services.
KKV Trademark Application Published for Opposition
The USPTO has published the KKV trademark application for opposition. The application covers a wide range of goods including medical supplies, food products, household appliances, tools, chemicals, paper goods, textiles, and more. The publication allows for a period where third parties can oppose the trademark registration.
NEUTOUQ Trademark Application Published for Opposition
The USPTO has published the trademark application for 'NEUTOUQ' for opposition. The application covers a wide range of goods and services, including non-medicated cleansers, cosmetics, textiles, and wholesale/retail store services for pharmaceutical and medical supplies.
SIGMIR Trademark Application Published for Opposition
The USPTO has published the SIGMIR trademark application for opposition, related to microbial inoculants, seed treatments, and agricultural chemicals. The application was published on March 26, 2026, following a filing date of September 17, 2025.
Hepatofilin Trademark Application Published for Opposition
The USPTO has published the trademark application for 'Hepatofilin' for opposition. The application covers nutritional supplements, herbal teas for medicinal purposes, and medicinal drinks. The publication date is March 26, 2026.
ATTOCONEXA Trademark Application Published for Opposition
The USPTO has published the trademark application for ATTOCONEXA, filed by a pharmaceutical entity. This publication initiates a period for opposition before the trademark can be officially registered.
Valalto Life Beyond Care Trademark Application Published
The USPTO has published the trademark application for 'Valalto Life Beyond Care' for opposition. The application covers a wide range of goods and services, including pharmaceuticals, dietetic foods, and retail services for medical supplies. The publication date is March 26, 2026.
New Trademark Application Published for Opposition
The USPTO has published a new trademark application for opposition, related to veterinary preparations and animal dietary supplements. The application was filed on November 18, 2025, and the opposition period begins March 26, 2026.
ATTOSCRIPTA Trademark Application Published for Opposition
The USPTO has published the trademark application for 'ATTOSCRIPTA' for opposition. The application covers a wide range of research reagents, diagnostic preparations, and chemicals for scientific and industrial use, primarily within the pharmaceutical and biotechnology sectors. The publication opens a period for third parties to oppose the trademark registration.
ATTOAPOLLO Trademark Application Published for Opposition
The USPTO has published the ATTOAPOLLO trademark application for opposition. This trademark application covers a wide range of research preparations, reagents, and diagnostic tools for medical, veterinary, and scientific research purposes. The publication marks a step in the trademark registration process, allowing for potential objections before final approval.
ATTOIRIDA Trademark Application Published for Opposition
The USPTO has published the ATTOIRIDA trademark application for opposition. The application covers a broad range of chemicals, reagents, and research preparations for industrial, scientific, and diagnostic use, including those related to pharmaceuticals and biotechnology. The publication opens a period for third parties to oppose the trademark registration.
SAQUELTA Trademark Application Published for Opposition
The USPTO has published the trademark application for SAQUELTA, related to pharmaceutical and medical preparations for treating cancers and dermatological diseases. The application was published for opposition on March 26, 2026, with a filing date of November 19, 2025.
CMS Seeks Public Comment on Information Collection Activities
The Centers for Medicare & Medicaid Services (CMS) is seeking public comment on its intention to collect information from the public, as required by the Paperwork Reduction Act. This notice provides an opportunity for comment on the necessity, utility, and burden estimates of proposed information collections, including a revision for the Social Security Office (SSO) Report of State Buy-in Problems.
Comment on CMS Agency Information Collection Activities notice
The Centers for Medicare and Medicaid Services (CMS) is providing a notice regarding agency information collection activities. This notice allows the public to submit comments on the activities, which may include data collection forms or surveys used by CMS.
Proposed 30-Day Comment Request: Clinical Trials Reporting Program Database
The National Institutes of Health (NIH) is seeking public comment on a proposed extension for the Clinical Trials Reporting Program (CTRP) Database. This notice provides an additional 30-day comment period for the data collection project, which aims to consolidate reporting for NCI-supported clinical research.
Proposed TANF Pilot Evaluation Information Collection Activity
The Department of Health and Human Services (HHS) is proposing to collect data for a new Temporary Assistance for Needy Families (TANF) Pilot Evaluation. This initiative, authorized by the Fiscal Responsibility Act of 2023, aims to test new outcomes-based performance benchmarks in the TANF program. Public comments are being solicited on the proposed data collection instruments.
Reducing Bureaucracy and Burden for Refugee Resettlement Programs
The Administration for Children and Families (ACF) is issuing a direct final rule to rescind obsolete provisions of the State Legalization Impact Assistance Grants regulations (45 CFR part 402). This action aims to reduce regulatory burdens and streamline processes for refugee resettlement programs. The rule is effective May 26, 2026, unless significant adverse comments are received by that date.
Proposed Rule: Reducing Bureaucracy for Human Services and Emergency Response Programs
The Administration for Children and Families (ACF) has proposed amending regulations concerning the care of mentally ill nationals and assistance for citizens returned from foreign countries. The goal is to eliminate unnecessary or obsolete regulations, reducing bureaucracy for human services and emergency response programs. Public comments are due by April 27, 2026.
Proposed Rule: Reducing Bureaucracy and Burden for Native American Programs
The Administration for Children and Families (ACF) has proposed amending regulations under the Native American Programs Act to eliminate unnecessary or obsolete requirements. This proposed rule aims to reduce bureaucracy and burden for Native American programs. Written comments must be received by April 27, 2026.
ACF Congressionally Directed Community Projects Uniform Project Description - OMB Review
The Administration for Children and Families (ACF) is requesting a 3-year extension with revisions to the Congressionally Directed Community Projects—Universal Project Description (CDCP-UPD) information collection activity. The revisions aim to simplify language and reduce the application burden for an estimated 125 annual recipients.
CMS Proposes Information Collection; Seeks Public Comment
The Centers for Medicare & Medicaid Services (CMS) has published a notice proposing to collect information and is seeking public comment. The comment period for this proposed collection ends on May 26, 2026.
NIH Center for Scientific Review Announces Closed Meetings
The National Institutes of Health (NIH) has published a notice announcing several upcoming closed meetings for the Center for Scientific Review. These meetings, scheduled for April 2026, will involve the review and evaluation of grant applications, which may contain confidential commercial or personal information.
MYHEALTHHOME Trademark Renewal for Healthcare Information Services
The USPTO has renewed the MYHEALTHHOME trademark (TM86543864) for healthcare information services. The renewal was effective March 26, 2026, and pertains to services providing patients secure electronic access to their health information.
MIND BEACON intent to use trademark for mental health computer hardware
The USPTO has received an intent-to-use trademark application for 'MIND BEACON'. The application covers computer hardware and software related to mental health services, including therapy, monitoring, and virtual communication tools. This filing indicates a planned offering in the mental health technology sector.
Cancer Nutrition Consortium Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark for Cancer Nutrition Consortium (TM86614231), which covers services related to nutritional guidance and support. The renewal is effective March 26, 2026.
BIOSKRYB GENOMICS Trademark Renewal for Medical Services
The United States Patent and Trademark Office has renewed the trademark 'BIOSKRYB GENOMICS' for services including medical testing, genetic analysis, and research. The renewal is effective March 26, 2026, and covers a broad range of diagnostic, analytical, and research services in the fields of genetics and genomics.
Cora Physical Therapy Trademark Renewal
The USPTO has renewed the trademark 'Cora Physical Therapy' (TM90151884) for services including physical therapy, occupational therapy, speech therapy, and telehealth. The renewal is effective March 26, 2026.
CORA PHYSICAL THERAPY Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'CORA PHYSICAL THERAPY' (TM90151886). The renewal is effective March 26, 2026, and covers services including physical therapy, occupational therapy, speech therapy, and telehealth.
TREATING EVERYONE RIGHT trademark renewed
The USPTO has renewed the trademark 'TREATING EVERYONE RIGHT' (TM90151888), originally filed on September 1, 2020. The renewal is effective March 26, 2026, and covers services including physical therapy, occupational therapy, speech therapy, pediatric therapy, in-home health care, sports medicine, and telehealth.
CORAKIDS trademark renewed for pediatric therapy services
The USPTO has renewed the CORAKIDS trademark (TM90151889) for pediatric therapy services, including physical, occupational, and speech therapy. The renewal is effective March 26, 2026.
REJUVENATIONMD Trademark Renewal
The USPTO has renewed the REJUVENATIONMD trademark (TM86159091) for medical and spa services, including procedures like chemical peels, microdermabrasion, and facials. The renewal is effective March 26, 2026.
Darkness Into Light Trademark Registration for Mental Health Services
The USPTO has registered the trademark 'Darkness Into Light' (TM86275109) for services including mental health counseling, psychological therapy, and public awareness campaigns related to suicide prevention. The registration was finalized on March 26, 2026, following a filing date of May 7, 2014.
HISTOMAP Trademark Registration for Medical Information Services
The USPTO has registered the trademark HISTOMAP (TM86285979) for medical information services. The registration, effective March 26, 2026, covers services including providing medical information, consultancy, and advisory services related to disease states and diagnoses.
MINDBEACON trademark application for SAAS mental health services
The USPTO has received a trademark application for the mark MINDBEACON, intended for use with Software as a Service (SAAS) and Platform as a Service (PAAS) offerings related to mental health monitoring, assessment, therapy, and training. The application is an intent-to-use filing with an expected effective date of March 26, 2026.
Registered Trademark CLEAN for Nutritional Supplements
The USPTO has registered the trademark "CLEAN" (TM85374918) for nutritional supplements and related health and dietary services. The registration was finalized on March 26, 2026, following a filing date in 2011. This registration pertains to goods and services within International Class 044.
Trademark Renewal for Neurosurgery Services
The USPTO has renewed trademark TM88835600 for NN Northern Neurosurgery & Spine for medical services, specifically neurosurgery. The renewal is effective March 26, 2026, with the original filing date in 2020.
Satellite Healthcare Trademark Renewal
The USPTO has renewed the trademark application TM88750011 for Satellite Healthcare, which covers medical services and dialysis therapies for kidney disease treatment. The renewal is effective March 26, 2026.
Lighthouse Foot and Ankle Center Trademark Renewal
The USPTO has renewed the trademark for Lighthouse Foot and Ankle Center, covering medical and podiatry services. The renewal is effective March 26, 2026, and was filed on January 13, 2020.
Intent to Use Trademark Application for Computer Hardware
The USPTO has received an intent-to-use trademark application (TM90188673) for computer hardware related to mental health services, therapy, and educational programs. The application covers a wide range of hardware, software, and services aimed at supporting mental health assessment, treatment, and education.
POOLWERX Trademark Renewal for Medical Services
The USPTO has renewed the trademark 'POOLWERX' for services including landscape design, installation, maintenance, repair, and cleaning of swimming pools, spas, and fences. The renewal is effective March 26, 2026, and covers a range of related retail, wholesale, and consulting services.
MEDSPECIALTY intent to use trademark application filed
The USPTO has received an intent-to-use trademark application for the mark MEDSPECIALTY. The application, filed on March 16, 2023, covers a broad range of healthcare management and benefit administration services, including insurance claims processing and cost management.
MEDGOV Trademark Intent to Use Application
The USPTO has received an intent to use trademark application (TM97842232) from MEDGOV for services related to healthcare management, benefit management, insurance administration, and claims processing. The application was filed on March 16, 2023.
Wisconsin Diagnostic Laboratories Trademark Registration
The USPTO has registered the trademark 'WISCONSIN DIAGNOSTIC LABORATORIES' (TM86867218) for medical and testing services. The registration was finalized on March 26, 2026, following a filing date of January 6, 2016.
BG Bodygears Physical Therapy Trademark Renewal
The USPTO has renewed the trademark 'BG BODYGEARS PHYSICAL THERAPY' (TM86673010) for medical services, specifically physical therapy. The renewal is effective March 26, 2026, based on the original filing date of June 24, 2015.
USPTO Trademark Renewal for AT BODY GEARS - Physical Therapy Services
The USPTO has renewed trademark application TM86672999 for AT BODY GEARS, which offers physical therapy and related health care services. The renewal was effective as of March 26, 2026.
CORA PHYSICAL THERAPY Trademark Renewal
The USPTO has renewed the trademark 'CORA PHYSICAL THERAPY' (TM87516172) for medical services including massage therapy, occupational therapy, physical therapy, and speech therapy. The renewal is effective March 26, 2026.
DIGNITY HEALTH trademark registered for hospital services
The USPTO has registered the trademark "DIGNITY HEALTH" (TM85486297) for hospital services, including providing information and online databases related to hospital services. The trademark was filed on December 2, 2011, and registered on March 26, 2026.
The Neighborhood Therapist Trademark Renewal
The United States Patent and Trademark Office (USPTO) has processed a renewal for trademark application TM90885940, "The Neighborhood Therapist." This renewal pertains to services including mental health counseling, psychotherapy, and wellness services, and was renewed on March 26, 2026.
CoraKids physical therapy program trademark renewed
The USPTO has renewed the trademark registration for the "CoraKids physical therapy program." This renewal covers services including physical therapy, occupational therapy, and speech therapy for pediatric patients. The renewal was effective on March 26, 2026.
Cure Pet Cancer trademark application cancelled
The USPTO has cancelled the trademark application TM86620079 for 'Cure Pet Cancer'. The application, filed on May 5, 2015, was for medical services related to pet cancer, including fundraising and public awareness activities. The cancellation date is March 26, 2026.
Wisconsin Diagnostic Laboratories Trademark Registration
The USPTO has registered the trademark 'WISCONSIN DIAGNOSTIC LABORATORIES' (TM86867010) for medical diagnostic testing and related information services. The registration was finalized on March 26, 2026, following a filing date of January 6, 2016.
Texas Skull Base Physicians Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'Texas Skull Base Physicians' (TM86963327) for medical clinic services. The renewal is effective March 26, 2026, based on an original filing date of April 4, 2016.
PRETTY PERFECT YOU trademark renewed
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'PRETTY PERFECT YOU' (TM88707137) for cosmetic skin care services, including the injection of dermal fillers and botulinum toxin. The renewal is effective March 26, 2026.
Cancelled USPTO Trademark Application for Health and Nutrition Guidance
The USPTO has cancelled trademark application TM85375755, which sought to cover health, dietary, and nutritional guidance services. The application was originally filed on July 20, 2011, and was marked as cancelled on March 26, 2026.
CLEAN CLEANSE Trademark Registration - Medical Services
The USPTO has registered the trademark "CLEAN CLEANSE" for services including nutritional and dietary supplements, health guidance, and providing health and nutrition information online. The registration was finalized on March 26, 2026, based on a filing date of July 20, 2011.
Black Tie Event Services Trademark Registration
The USPTO has registered the trademark "Black Tie Event Services" for the rental of shower and sanitary facility trailers. The trademark application was filed in 2011 and officially registered on March 26, 2026.
Dignity Health Trademark Registration - Medical Services
The USPTO has registered trademark TM85473422 for Dignity Health, covering hospital services and providing information in the field of hospital services. The trademark was registered on March 26, 2026, with a filing date of November 15, 2011.
Dignity Health Registered Trademark Application TM85484353
The USPTO has registered the trademark TM85484353 for Dignity Health, related to online computer databases for hospital services. The trademark was registered on March 26, 2026, with a filing date of November 30, 2011.
BODYGUIDES Registered Trademark for Health Care Services
The USPTO has registered the trademark BODYGUIDES for health care services, specifically Bodywork therapy and Nutritional therapy services. The registration was finalized on March 26, 2026, following a filing date of January 9, 2014.
EVOK Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed trademark application TM86514453 for the mark 'EVOK'. The renewal is effective March 26, 2026. The trademark covers services including catering, temporary accommodation, hotel services, and health spa treatments.
SUPERCLINIC Trademark Renewal - Medical Clinics Services
The USPTO has renewed the trademark 'SUPERCLINIC' (TM86351481) for medical clinic services. The renewal was effective March 26, 2026, based on a filing date of July 29, 2014.
EMCOR Customer Solutions Center Trademark Renewal
The USPTO has renewed the trademark 'EMCOR Customer Solutions Center' (TM86656674) for landscaping design, horticultural services, and snow removal. The renewal is effective March 26, 2026.
Enhancing Human Mechanics Trademark Cancelled
The United States Patent and Trademark Office (USPTO) has cancelled the trademark 'Enhancing Human Mechanics' (TM86673008) effective March 26, 2026. This cancellation pertains to services related to physical therapy and medical rehabilitation.
POTTY PROS trademark application cancelled
The USPTO has cancelled the trademark application TM86692126 for 'POTTY PROS', which was filed on July 14, 2015, for the rental of portable toilets. The cancellation was effective March 26, 2026.
The Smart Human Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed trademark application TM86695842 for 'The Smart Human'. This renewal pertains to services related to health and wellness information, specifically concerning chemicals and toxins in daily life. The renewal is effective March 26, 2026.
Wiggle Room Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'Wiggle Room' (TM86971145) for medical services, including physical therapy. The renewal is effective March 26, 2026.
Smart Recovery 4-Point Program Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed trademark application TM87753440 for 'Smart Recovery 4-Point Program'. This renewal pertains to services related to addiction treatment and rehabilitation.
COLOR ASYLUM Trademark Renewal
The USPTO has renewed the trademark 'COLOR ASYLUM' (TM86984258) for beauty salon and cosmetic skin care services. The renewal is effective March 26, 2026.
Potty Pros Trademark Renewal for Portable Toilet Services
The USPTO has renewed the trademark for 'Potty Pros' for services including providing and renting portable toilets and sanitation facilities. The renewal is effective March 26, 2026.
TATT2REVISE Trademark Renewal - Tattoo Removal Services
The USPTO has renewed the TATT2REVISE trademark (TM88598640) for services related to non-laser tattoo removal. The renewal is effective March 26, 2026, and covers services such as partial tattoo removal and tattoo cover-up.
Band Together trademark renewed
The USPTO has renewed the trademark 'Band Together' (TM88602471) for services including music therapy for individuals with autism and charitable services promoting autism awareness. The renewal is effective March 26, 2026.
LAS MADRINAS MEDICAL CENTERS Trademark Renewal
The USPTO has renewed the trademark 'LAS MADRINAS MEDICAL CENTERS' (TM88329916) for medical services. The renewal is effective until March 26, 2026, and covers a range of services including medical clinic services, treatment of illness and injury, and medical imaging.
NEIGHBORHOOD Trademark Renewal for Medical Services
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'NEIGHBORHOOD' (TM88703284) for a variety of medical and health services. The renewal was effective March 26, 2026, following a filing date in 2019.
ELINA ORGANICS Trademark Renewal
The USPTO has renewed the trademark 'ELINA ORGANICS' (TM88593276) for cosmetic and non-medicated skincare products made from organic ingredients. The renewal is effective March 26, 2026.
M·U·G Men's Ultimate Grooming Trademark Renewal
The USPTO has renewed the trademark 'M·U·G Men's Ultimate Grooming' (TM88462799) for medical services, specifically beauty salons. The renewal is effective March 26, 2026, building upon the original filing date of June 6, 2019.
ENDO AESTHETICS Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'ENDO AESTHETICS' (TM88514666) for medical services. The renewal is effective March 26, 2026, and covers educational services, medical information provision, and related counseling.
Oregon Health Authority Highlights Colorectal Cancer Awareness Month
The Oregon Health Authority (OHA) issued a notice highlighting Colorectal Cancer Awareness Month and encouraging residents to undergo screening. The notice provides statistics on colorectal cancer in Oregon and emphasizes the importance of early detection and screening, particularly for individuals under 50.
Lead Exposure and Prevention Advisory Committee Charter Renewal
The Centers for Disease Control and Prevention (CDC) has renewed the charter for the Lead Exposure and Prevention Advisory Committee (LEPAC). The renewal is effective for a two-year period, extending through March 11, 2028.
Advisory Committee on Immunization Practices Meeting Cancellation
The Centers for Disease Control and Prevention (CDC) has issued a notice cancelling the Advisory Committee on Immunization Practices (ACIP) meeting previously scheduled for March 18-19, 2026. This cancellation is due to a court order in the case American Academy of Pediatrics et al. v. Kennedy et al.
Electric Scalpel HF Bipolar Cable Safety Information
The ANSM has issued a safety alert regarding an action taken by Olympus Winter & IBE GmbH concerning their electric scalpel HF bipolar cable. Healthcare facilities have been informed of this safety action, registered under number R2607994.
EMA CHMP Meeting: 5 New Medicines, 13 Indication Extensions Recommended
The EMA's CHMP recommended five new medicines for approval and extensions of therapeutic indications for 13 existing medicines at its March 2026 meeting. The committee also confirmed a refusal for a marketing authorisation change and noted the withdrawal of an application for a new Alzheimer's treatment.
Ketorolac Tromethamine Ophthalmic Solution Revision Notice
The USP has issued a notice of intent to revise the Ketorolac Tromethamine Ophthalmic Solution monograph. The revision aims to extend the official date and adjust the pH limit from 6.8-7.9 to 6.2-7.9 to accommodate FDA-approved products.
General Chapter Prospectus for LG Polymer Implant Drug Products
The USP has issued a General Chapter Prospectus for <1158> LG Polymer Implant Drug Products – Characterization Methods. This proposed chapter aims to provide a compendial framework for product quality and performance testing of LG polymer implant drug products, focusing on specific characterization needs for these long-acting dosage forms. Stakeholders are invited to provide input.
Levocarnitine Monograph Revision: Proposed Direct Chiral HPLC Method
The USP has proposed a direct chiral HPLC method to revise the Enantiomeric Purity test in the Levocarnitine monograph due to the temporary unavailability of the required derivatization reagent (+)-FLEC. This proposed method is currently open for public comment.
USP Revises Select Chemical Standards
The USP has announced revisions to the chemical information of select standards, with updates becoming official on October 1, 2026. These changes affect specific USP monographs for various drug substances and formulations, including Candesartan Cilexetil and Hydrochlorothiazide Tablets, Dronabinol, and several Verapamil Hydrochloride products.
USP-NF Changes: Redesign-Only Standards Official Date Policy
The United States Pharmacopeia (USP) has updated its policy regarding the official date for "redesign-only" documentary standards in the USP-NF Online platform. Previously, these standards retained their original publication date, but now they will have a "To Be Official" status and become official six months after posting, effective March 27, 2026.
Michigan Medicaid: Diabetes/Weight Loss Drugs Dispensed Per Requirements
The HHS Office of Inspector General (OIG) reported that selected diabetes and weight loss drugs dispensed to Michigan Medicaid managed care enrollees were in accordance with federal and state requirements. The audit found that Michigan ensured managed care organizations followed all applicable coverage and utilization requirements, including prior authorizations and quantity limits.
Salmonella Infections Linked to Backyard Poultry
The Ohio Department of Health issued a notice regarding the risk of Salmonella infections from backyard poultry. The notice highlights that dozens of human infections occur annually in Ohio linked to contact with poultry, with 20% of nationwide cases being children under 5.
Guidance on Incorporating Voluntary Patient Preference Information
The FDA has issued updated guidance on incorporating voluntary patient preference information (PPI) into medical device submissions. This guidance provides recommendations on methods and contexts for collecting and submitting PPI to aid FDA decision-making throughout the total product lifecycle for biologics and medical devices.
Mabquest Therapeutics Trademark Application Published for Opposition
The USPTO has published the trademark application for 'Mabquest Therapeutics' for opposition. The application covers pharmaceutical products for treating cancer, autoimmune diseases, and inflammatory disorders, among other related medical preparations and diagnostic agents. The publication date is March 26, 2026, with a filing date of July 29, 2025.
Pharmalys Laboratories Trademark Application Published for Opposition
The USPTO has published the trademark application for 'P Pharmalys Laboratories' for opposition. The application covers a range of pharmaceutical products, dietary supplements, and medical foods. The publication date is March 26, 2026, with a filing date of September 19, 2025.
Adipopharma Trademark Application Published for Opposition
The USPTO has published the Adipopharma trademark application (TM79425256) for opposition. The application covers scientific and technological services related to drugs and pharmaceuticals, as well as various pharmaceutical and veterinary preparations.
TRIAGID Trademark Published for Opposition
The USPTO has published the trademark application for 'TRIAGID' for opposition. The application covers a wide range of services including research and development of computer software, psychological services, and educational/training services in mediation and counseling.
EYE HERO Trademark Published for Opposition
The USPTO has published the trademark application for 'EYE HERO' for opposition, with a publication date of March 26, 2026. The application covers services including vision screening, therapy, occupational therapy, and education/training.
DEEPRENEW Trademark Application Published for Opposition
The USPTO has published the trademark application for 'DEEPRENEW' for opposition. The application covers toiletries, essential oils, cleaning preparations, and human healthcare, hygiene, and beauty care services. The publication date is March 26, 2026, with a filing date of November 19, 2025.
CEBREO Trademark Application Published for Opposition
The USPTO has published the trademark application for CEBREO, which covers medical systems and devices for physiological signal acquisition and monitoring. The publication opens a period for opposition from interested parties.
ETIENNE SEKOLA PARIS Trademark Publication
The USPTO has published the trademark application for 'ETIENNE SEKOLA PARIS' for opposition. The application covers a range of goods and services including medical services, pharmaceutical products, and cosmetics, with a filing date of November 19, 2025.
ROSEMIN Trademark Application Published for Opposition
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'ROSEMIN' for opposition. The application covers a wide range of goods and services, including fashion design consulting, cosmetics research, jewelry, watches, and various cosmetic products and retail services.
Sagistar Trademark Application Published for Opposition
The USPTO has published the trademark application for 'SAGISTAR' for opposition. The application covers software, scientific apparatus, and medical devices related to radiotherapy, diagnosis, and patient treatment. The filing date was November 19, 2025.
HUNDREDVISION Trademark Application Published
The USPTO has published the trademark application for HUNDREDVISION, which includes services related to healthcare, software, and business management. The application was published for opposition on March 26, 2026, with a filing date of November 18, 2025.
DEEP NATURE Trademark Publication
The USPTO has published the trademark application 'DEEP NATURE' for opposition. The application covers services including beauty salons, solariums, saunas, massage, and aromatherapy. The publication date is March 26, 2026, with a filing date of August 8, 2025.
REMEXIAN trademark published for opposition
The USPTO has published the trademark application for REMEXIAN for opposition. The application covers a wide range of medical, hygienic, and beauty care services, as well as medical instruments and retail services for pharmaceutical and healthcare products.
CARDIOSCAN Trademark Published for Opposition
The USPTO has published the CARDIOSCAN trademark application for opposition. The application covers data processing, data management, and medical/diagnostic services, particularly in relation to cardiac medical services. The publication date is March 26, 2026.
RILAVI Trademark Application Published for Opposition
The USPTO has published the RILAVI trademark application for opposition. The application covers a range of services including AI-based conversational systems, medical services for computer-based support, and software for treating postural instability vertigo. The publication date is March 26, 2026.
WELLSYSTEM CRYOWAVE Trademark Opposition Published
The USPTO has published the trademark application for WELLSYSTEM CRYOWAVE for opposition. The application covers services related to cryotherapy, cold therapy, and related medical and therapeutic apparatus. The publication date is March 26, 2026.
KINU GAWA Trademark Publication for Opposition
The USPTO has published the KINU GAWA trademark application for opposition. The application covers a broad range of services including medical care, spa services, retail goods, food and beverage services, temporary accommodations, and educational/wellness workshops. The publication marks a step in the trademark registration process.
APISENSE Trademark Application Published for Opposition
The USPTO has published the trademark application for 'APISENSE' for public opposition. The application covers a wide range of goods and services, including pet supplies, beehive management software utilizing AI and IoT, animal healthcare, and scientific research services related to bee health and environmental monitoring.
CRUMB trademark application published for opposition
The USPTO has published the trademark application for 'CRUMB' for opposition. The application covers a range of goods including dietary supplements for animals, pet health monitoring software, and smart pet tags, as well as services such as veterinary advisory and information services.
C THE SIGNS Trademark Application Published
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'C THE SIGNS'. This application covers a range of information technology and software services related to healthcare, including AI-driven tools for cancer assessment, diagnosis, and treatment.
DEA Houston Fentanyl Message at Baseball Game
The DEA's Houston Division participated in a public outreach event at a baseball game on March 26, 2026, to spread awareness about fentanyl. The division set up a booth to distribute educational materials and giveaways.
Patent Application: Cinchable Loops for Knotless Tissue Spanning
The USPTO has published a new patent application, US20260083450A1, detailing cinchable loops for knotless tissue spanning. The application describes a suture construct and an inserter tool for medical procedures. This is a routine publication of a patent application.
Medline Namic Angiographic Control Syringes Recalled Due to Unwinding Risk
Health Canada has issued a Type I recall for Medline Namic Angiographic Control Syringes due to a risk of the syringe rotating adaptor unwinding during use, which could lead to procedural delays or death. Healthcare professionals are advised to contact the manufacturer for more information and to destroy affected products.
SFDA CEO Discusses AI's Role in Drug Development and Regulatory Efficiency
The CEO of the Saudi SFDA highlighted the significant contributions of Artificial Intelligence (AI) to accelerating drug development, reducing costs, and enhancing regulatory efficiency for medicines, medical devices, and food products. The SFDA has launched an AI laboratory and developed a digital twin to integrate emerging innovations and streamline approval processes.
SFDA CEO Congratulates Saudi Leadership on Eid al-Fitr
The CEO of the Saudi Food and Drug Authority (SFDA) extended Eid al-Fitr greetings to the Saudi leadership and people. The announcement also highlighted the SFDA's role in ensuring the safety of food, medicine, and medical devices during the Umrah season.
SFDA Grants Breakthrough Designation to Bemlayo for Obesity/Overweight
The Saudi Food and Drug Authority (SFDA) has granted Eli Lilly's drug Bemlayo (Orforglipron) Breakthrough designation. This designation expedites the review process for innovative treatments for serious diseases but does not constitute marketing authorization.
SFDA grants orphan drug designation to Sephience for HPA/PKU
SFDA grants orphan drug designation to Sephience for HPA/PKU
SFDA Grants Orphan Drug Designation to Agamree for Duchenne Muscular Dystrophy
The Saudi Food and Drug Authority (SFDA) has granted Santhera Pharmaceuticals orphan drug designation for Agamree (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD). This designation allows for a dedicated regulatory pathway for serious or rare diseases but does not constitute formal product registration.
Patent US12582321B2 for Cardiac Diastolic Function Assessment
The USPTO has granted patent US12582321B2 for a cardiac diastolic function assessment method, device, and system. The patent, assigned to CARDIOSTORY INC., was filed on May 20, 2019, and issued on March 24, 2026. It details a non-invasive method for assessing cardiac diastolic function using vibration information.
Smart toothbrush patent tracks and removes dental plaque
The USPTO has granted a patent (US12582319B2) to International Business Machines Corporation for a smart toothbrush designed to track and remove dental plaque. The technology involves emitting light, detecting reflections, and analyzing them to determine plaque presence and location.
Olympus Endoscope System Patent Granted
The USPTO has granted patent US12582293B2 to Olympus Medical Systems Corp. for an insertion instrument and endoscope system. The patent details specific configurations for an insertion section, including a distal end portion with multiple conduits designed for improved functionality.
Patent Granted for Bone Clamp
The United States Patent and Trademark Office has granted patent US12582428B2 to Brook Orthopaedics Ltd for a bone clamp. The patent, effective March 24, 2026, describes a clamp designed for bone fracture fixation or prevention.
Lithotriptor Spacers and Method Patent
The USPTO has granted patent US12582427B2 for lithotriptor spacers and a related method, assigned to Olympus America Inc. The patent details a medical device with spacers extending from a lithotriptor's shaft, featuring longitudinal pathways and potentially an elastomer material.
Bone align and joint preparation device and method
The USPTO has granted patent US12582422B2 for a bone alignment and joint preparation device and method to MEDARTIS AG. The patent details a system for bone displacement, including anchoring and tool engaging portions, and a compression-distraction mechanism.
USPTO Patent Grant: Intraoperative Adjustable Guides, Systems, and Methods
The USPTO has granted patent US12582421B2 for intraoperative adjustable guides, systems, and methods. The patent was assigned to Wright Medical Technology, Inc. and covers devices designed for patient-specific bone engagement and adjustable guide surfaces.
Patent US12582420B2: Osteotomy cutting systems and surgical techniques
The USPTO has granted patent US12582420B2 for osteotomy cutting systems and surgical techniques related to bunion correction. The patent, filed on March 13, 2023, details specific surgical methods and apparatus for correcting bunions by coupling surgical tools to the cuneiform and metatarsal bones.
Tibial Suprapatellar Entry Portal System Patent Granted
The United States Patent and Trademark Office (USPTO) has granted patent US12582419B2 for a tibial suprapatellar entry portal system. The patent, assigned to ORTHOXEL DAC, was granted on March 24, 2026, following a filing date of May 26, 2021.
Knee Surgery System Patent Granted
The USPTO has granted a patent (US12582418B2) to 4-Bar Precision Sports Medicine LLC for a knee surgery system, robot, and techniques for computer-guided knee repair and reconstruction. The patent was granted on March 24, 2026, following an application filed on March 10, 2023.
Oscillating Decortication Burr Assembly Patent Grant
The USPTO has granted patent US12582417B2 for an oscillating decortication burr assembly. This patent covers a device designed for decorticating articular surfaces of human body joints, featuring a burr, support post, and handle that imparts oscillation to the burr.
Surgical tool for scraping and collecting bone particles
The USPTO has granted a patent (US12582416B2) to META TECHNOLOGIES S.R.L. for a surgical tool designed for scraping and collecting bone particles. The patent details specific components including a handle, collection chamber, stem, blade, and a spacer that defines a passage for bone particles.
Patent US12582423B2 for bone tunnel formation
The USPTO has granted patent US12582423B2 to Integrity Medical Services Inc. for a method and tool for forming bone tunnels, relevant to orthopedic surgical procedures. The patent was issued on March 24, 2026, following an application filed on April 25, 2025.
USPTO Patent Grant for Electromagnetic Imaging
The USPTO has granted patent US12582316B2 to EMvision Medical Devices Ltd for an apparatus and process for electromagnetic imaging. The patent describes a computer-implemented method for generating image data of internal object features without tomographic reconstruction, utilizing weighted mapping of scattering data.
Patent Grant US12582320B2 for Vessel Assessment Method
The USPTO has granted patent US12582320B2 for a method of assessing a vessel. The patent, filed on July 7, 2020, details a process for calculating a pressure ratio using pressure measurements between identified characteristics within a vessel.
Patent US12582318B2: Illumination unit for open surgery imaging
The USPTO has granted patent US12582318B2 to OLYMPUS Winter & Ibe GmbH for an illumination unit designed for fluorescence imaging during open surgery. The patent details a specific design for an illumination unit intended to improve visibility and diagnostic capabilities in surgical environments.
Patent Grant US12582317B2: Detecting device and measuring apparatus
The USPTO has granted patent US12582317B2 to Seiko Epson Corporation for a detecting device and measuring apparatus. The patent describes a device with a substrate, a matrix of detecting elements, and organic EL light emitting elements.
USPTO Patent Grant for ECG Analysis Apparatus
The USPTO has granted patent US12582315B2 for an electrocardiogram analysis apparatus to CARDIO INTELLIGENCE INC. The patent covers a system utilizing machine learning to detect paroxysmal arrhythmia from patient ECG data. The grant is effective March 24, 2026.
USPTO Patent Grant for Physiological Monitoring System
The USPTO has granted patent US12582313B2 to Masimo Corporation for a physiological monitoring system. The patent covers systems and methods for advanced signal processing of patient physiological data before transmission for display on a mobile computing device.
Slit Lamp and Biomicroscope Assembly Patent Granted
The USPTO has granted a patent (US12582312B2) for a slit lamp and biomicroscope assembly. The patent, filed on May 23, 2023, and granted on March 24, 2026, covers an assembly that includes a viewing system, an illumination system, and a positioning system with user interface controls.
Image pickup unit with resin in via holes for endoscope
The USPTO has granted patent US12582294B2 to OLYMPUS CORPORATION for an image pickup unit with resin in via holes for an endoscope. The patent details a specific design for an image pickup substrate, solder resist film, and bonding terminal intended for use in endoscopic devices.
Pharmacy Policy on Reporting Loss or Theft of Controlled Substances
The Massachusetts Board of Registration in Pharmacy has issued Policy 2026-01, updating procedures for pharmacies and wholesalers to report confirmed losses or thefts of controlled substances. The policy requires reporting within 7 calendar days of discovery for all losses related to theft, pilferage, or diversion, regardless of quantity or schedule, and significant losses of Schedule II-VI substances.
Pharmacy Reporting Policy for Controlled Substance Loss or Theft
The Massachusetts Board of Registration in Pharmacy has issued Policy 2026-01, updating procedures for licensed pharmacies and wholesalers to report confirmed losses or thefts of controlled substances. The policy requires reporting within 7 days of confirmed losses, including those from theft, pilferage, or diversion, regardless of quantity or schedule, and significant losses of Schedule VI substances.
USPTO Patent Grant US12582303B2 for Medical Scope
The USPTO has granted patent US12582303B2 to KARL STORZ Imaging, Inc. for a medical scope featuring a capacitive sensor unit. This innovation allows for control of camera functions and identification of medical procedures or users via sensors on the scope's handle.
Vitrectomy probe with magnetic cutter granted to Alcon Inc
The USPTO has granted patent US12582549B2 to Alcon Inc. for a vitrectomy probe featuring a magnetically driven cutter. The patent, filed on May 2, 2024, describes a probe with a magnetic cutter that can be moved by an induced magnetic field.
US patent grant for electronic component holding member and endoscope
US patent grant for electronic component holding member and endoscope
USPTO Patent Grant: Fetal Analyte Monitoring Device
The USPTO has granted patent US12582335B2 for a device designed to monitor fetal analyte concentrations. The device utilizes a biosensor and a protrusion for insertion into fetal tissue to detect analyte levels, with VitalTrace Pty Ltd listed as the assignee.
Lung visualization ultrasound system patent granted
The USPTO has granted patent US12582328B2 for a lung visualization ultrasound system assigned to Covidien LP. The patent details a system and method for generating ultrasound images integrated with a 3D model for improved lung visualization.
USPTO Patent Grant for Vital Signal Detection Device
The USPTO has granted patent US12582327B2 to SAKURA TECH CORPORATION for a portable non-contact vital signal detection device. The patent covers a device that can detect vital signals from both the front and back of the device, potentially enhancing its utility in various healthcare and monitoring applications.
Ophthalmic apparatus patent US12582309B2 granted to Topcon Corporation
The United States Patent and Trademark Office has granted patent US12582309B2 for an ophthalmic apparatus to Topcon Corporation. The patent, effective March 24, 2026, describes an apparatus for calculating intraocular parameters using OCT technology.
Ophthalmic apparatus and method patent granted to Topcon Corporation
The USPTO has granted patent US12582308B2 to Topcon Corporation for an ophthalmic apparatus and method. The patent covers a system that uses OCT imaging and tilt information to control a fixation target presented to a subject's eye.
USPTO Patent Grant for Image Capturing Device and System
The USPTO has granted patent US12582307B2 to AILLIS INC. for an image capturing device and system designed for use in the oral cavity. The patent covers a device with a main body, grip, camera, and display for capturing and showing subject images.
Negative pressure gripping system and method patent US12582430B2
The USPTO has granted patent US12582430B2 for a negative pressure-based gripping system and method, assigned to Septulus AB. This patent covers a device designed to grip and retain a target, such as a human or animal heart, using negative pressure generated by a vacuum pump.
Intuitive Surgical patent: medical apparatus optical sensing
Intuitive Surgical patent: medical apparatus optical sensing
Analyte sensor devices, connections, and methods
The USPTO has granted patent US12582334B2 to Abbott Diabetes Care Inc. for analyte sensor devices, connections, and methods. The patent covers on-body analyte sensor units, packaging, loading systems, and applicators, as well as novel connection approaches for electrochemical analyte sensors.
Body Sway Measurement System Patent Granted to Bertec Corporation
The USPTO has granted patent US12582333B1 to Bertec Corporation for a body sway measurement system. The system utilizes an inertial measurement unit or camera and a data processor with a trained neural network to extract movement features and determine body sway parameters. The patent was filed on February 26, 2024.
Apple Inc. Patent for Piezoelectric Sensor with Resonating Microstructures
The USPTO has granted Apple Inc. a patent for a piezoelectric sensor system utilizing resonating microstructures to detect and amplify biological vibrations. The patent, filed in 2021, aims to improve the identification of specific biological signals for potential use in medical devices.
Patent Grant for Operative Accuracy Enhancement Using IMUs
The USPTO has granted patent US12582331B2 to DePuy Synthes Products, Inc. for systems, devices, and methods enhancing operative accuracy using inertial measurement units (IMUs). The patent covers the use of IMU data for surgical navigation, alignment, diagnosis, and intra-operative guidance.
Patent for computer-assisted shape measurements in surgery
The USPTO has granted patent US12582330B2 to Kaliber Labs Inc. for systems and methods to assist surgical procedures using computer-assisted shape measurements from video streams. The patent covers intraoperative measurements and overlays for procedures like arthroscopic surgery.
Magneto-mechanical capsules patent grant US12582329B2
The USPTO has granted patent US12582329B2 for magneto-mechanical capsules to Northern Digital Inc. The patent describes capsules with a body and multiple magnets, where a central magnet can oscillate to produce a magnetic field, potentially for diagnostic or surgical applications.
Patent US12582325B2 for Contactless Blood Oxygen Estimation
The USPTO has granted patent US12582325B2 for a contactless image-based blood oxygen estimation method. The patent, assigned to the University of Maryland, College Park, describes a system that estimates blood oxygen saturation using camera-captured images and spatial-temporal data analysis.
Sphygmomanometer Main Body Patent Granted
The USPTO has granted a patent (US12582322B2) to Omron Healthcare Co., LTD. for a sphygmomanometer main body. The patent, effective March 24, 2026, details a design incorporating electrode regions for measuring electrocardiogram waveforms alongside blood pressure.
Ophthalmic apparatus patent grant US12582311B2
The USPTO has granted patent US12582311B2 to Topcon Corporation for an ophthalmic apparatus. The patent describes a system for acquiring and assessing anterior segment images of the eye using OCT scanning and image processing techniques. This grant represents a new intellectual property right for the assignee.
Patent US12582310B1 for Ocular Refraction Test Apparatus Granted
The USPTO has granted patent US12582310B1 for a telescopic ocular refraction test apparatus, system, and method. The patent was granted to DR RP HOLDINGS, LLC and lists William Vincent Padula, II as the inventor. The patent details a system that includes a display for vision testing images and a telescope for patient use.
US Patent US12582306B2 for Dental Scanner and Data Transmission
The USPTO has granted US Patent US12582306B2 to MEDIT CORP. for a dental scanner and data transmission method. The patent covers an intraoral scanner with a camera module and dual-band communication for transmitting image data and control signals.
Patent US12582305B2 for Lighted Disposable Speculum Granted
The USPTO has granted patent US12582305B2 for a lighted disposable speculum to Medline Industries, LP. This patent covers a device designed to improve visibility during urological and pelvic examinations.
Ultrasonic Surgical Instrument Patent Granted
The USPTO has granted a patent (US12582431B2) to Cilag GmbH International for an ultrasonic surgical instrument. The patent covers an instrument with a body, shaft, and end effector designed for activation in different modes. The filing date was July 29, 2022.
USPTO Patent Grant: Ultrasonic Surgical Irrigation Sleeve
The USPTO has granted patent US12582432B2 for an ultrasonic surgical irrigation sleeve developed by Stryker European Operations Limited. This patent covers a specific design for an irrigation sleeve assembly intended for use with ultrasonic surgical instruments.
USPTO Patent Grant US12582434B1 for Excisional Devices
The USPTO has granted patent US12582434B1 for excisional devices and methods to TRANSMED7 LLC. The patent covers a platform device for material excision from vascular structures, designed for various clinical uses.
Patent for Retractable Protection on Surgical Cutting Tools
The USPTO has granted a patent (US12582435B2) to Medtronic PS Medical, Inc. for a surgical cutting device featuring retractable protection and/or sensing capabilities. The patent covers a design that allows a shield to extend beyond the cutting tool for enhanced safety during surgical procedures.
USPTO Patent Grant for Tele-Operated Surgery Systems
The USPTO has granted patent US12582438B2 to Intuitive Surgical Operations, Inc. for computer-assisted tele-operated surgery systems and methods, specifically focusing on cannula devices that facilitate workspace enlargement. The patent was filed on August 15, 2022, and officially granted on March 24, 2026.
Patent Grant US12582440B2 for Surgical Instrument Entry Guide
The USPTO has granted patent US12582440B2 for a surgical instrument entry guide to Intuitive Surgical Operations, Inc. The patent covers medical devices designed for surgical procedures, particularly those involving the manipulation of surgical instrument end effectors near the skin surface.
Electrode Apparatus for Nerve Denervation or Modulation
The USPTO has granted patent US12582442B2 for an electrode apparatus for nerve denervation or modulation in vivo, assigned to DEEPQURE, INC. The patent details an apparatus designed for in-vivo nerve treatment, including a main body, electrode unit, and guiding mechanisms.
Fetal intrauterine positioning device patent granted
The USPTO has granted a patent (US12582443B2) for a fetal intrauterine positioning fixation device and system. The patent was assigned to Xiamen Brana Design Co., Ltd. and lists Zhongtang Wang as the inventor. The device is designed for use in surgical procedures to adjust and fix a fetus's position within the maternal uterus.
Medical Device Patent US12582444B2 Granted
The United States Patent and Trademark Office (USPTO) has granted patent US12582444B2 to Arbutus Medical Inc. The patent, related to a medical device, was granted on March 24, 2026, following an application filed on June 18, 2024. This grant represents new intellectual property for the assignee.
Orthognathic Surgical Planning Apparatus Patent Granted
The USPTO has granted patent US12582445B1 for an apparatus designed for orthognathic surgical planning. The apparatus, assigned to King Saud University, aims to reduce planning time and errors in maxillary repositioning for procedures like the Le Fort I osteotomy.
Collapsible Surgical Fastener Patent Granted
The USPTO has granted a patent (US12582446B2) for a collapsible surgical fastener to Stryker European Operations Limited. The patent details a specific design for a surgical fastener and a method for its use in bone procedures.
Olympus Corporation Granted Patent for Endoscope Connector
The United States Patent and Trademark Office has granted patent US12582295B2 to Olympus Corporation for an endoscope tubular connector. The patent, filed on August 19, 2022, describes a connector designed to improve the connection between endoscope components.
USPTO Patent Grant for Biopsy Cap Seal
The USPTO has granted patent US12582296B2 for an internal seal for a biopsy cap, assigned to Boston Scientific Medical Device Limited. The patent details a seal designed for use with endoscope assemblies, featuring a unique flap or projection system to define an opening within a central lumen.
Medical Visualization System Patent Granted
The USPTO has granted patent US12582301B2 for a medical visualization system to AMBU A/S. The patent, filed on June 13, 2022, covers a monitor device that receives image data from a medical visualization device and displays live images alongside a stopwatch function.
Endoscope Control Element and Self-Locking Device Patent Granted
The USPTO has granted a patent (US12582298B2) to HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD. for an endoscope control element and self-locking device. The patent, filed on May 30, 2025, describes improvements to the control element's deformable portion to increase deformation amount and reduce resistance.
In vivo imaging apparatus, systems, and methods using optical nanoparticles
The USPTO has granted patent US12582302B2 to The Regents of the University of California for in vivo imaging apparatus, systems, and methods using optical nanoparticles. The patent covers techniques for illuminating and imaging tissues, such as cancer tissues, using upconverting nanoparticles to improve resolution and reduce imager size.
WPF Wolf's Protein Fasting Trademark Published for Opposition
The USPTO has published the trademark application for 'WPF Wolf's Protein Fasting' for opposition. The application covers a range of services related to dietary and nutritional advice, weight loss programs, and educational content in the field of nutrition.
MED-CYCLE Trademark Renewal
The USPTO has renewed the MED-CYCLE trademark (TM79397813) for a list of medical and pharmaceutical goods and services. The renewal is effective March 26, 2026, and the filing date for the renewal application was March 19, 2024.
SKIN ROCKS PRO trademark published for opposition
The USPTO has published the trademark application for 'SKIN ROCKS PRO' for opposition. The application covers a wide range of services including beauty care, medical services, and retail sales of beauty and health products. The publication opens a period for third parties to oppose the registration.
Herbalisté Trademark Registration - Class 044 Medical Services
The USPTO has registered the trademark 'Herbalisté' (TM79420299) for medical and beauty services in Class 044. The registration was finalized on March 26, 2026, following a filing date of February 25, 2025.
STIMCARDIO Trademark Application Published for Opposition
The USPTO has published the STIMCARDIO trademark application for opposition. The application covers a range of medical services and devices, including wearable biometric measurement devices, AI-powered therapy optimization software, and arrhythmia treatment devices. The publication date is March 26, 2026.
ECO ORIGIN Trademark Publication
The USPTO has published the ECO ORIGIN trademark application for opposition. The application covers the supply and distribution of various medical gases. The publication date is March 26, 2026, with a filing date of May 5, 2025.
Engineered Polynucleotide for Cancer Treatment
The USPTO has published a patent application detailing an engineered polynucleotide designed to treat cancer by regulating gene expression. The application, filed on July 17, 2025, describes compositions and methods involving polynucleotides that interact with pre-mRNA and spliceosomes.
Patent Application for cDNA Synthesis and Transcriptome Profiling
The USPTO has published a patent application (US20260085309A1) for compositions and methods related to cDNA synthesis and transcriptome profiling. The application details optimized template switching oligonucleotides designed to improve reverse transcription specificity and prevent concatemer formation. This is a new patent application filing, not a final rule or guidance.
Patent Application for Antisense Oligonucleotide Targeting TDP-43 mRNA
The USPTO has published a patent application (US20260085310A1) filed by NIPPON SHINYAKU CO., LTD. The application describes an antisense oligonucleotide targeting TDP-43 mRNA or pre-mRNA for potential therapeutic use. The filing date was May 26, 2023.
Patent Application: Compositions and Methods for Reducing RNA Levels
The USPTO has published a new patent application (US20260085311A1) detailing compositions and methods for reducing RNA levels and treating diseases caused by toxic gain-of-function proteins. The application was filed on June 20, 2023.
Patent Application: Cancer Treatment with Stat3 Decoy
The USPTO has published a new patent application (US20260085318A1) detailing methods for treating cancer using a STAT3 double-stranded, cyclic oligonucleotide decoy in combination with an immune checkpoint inhibitor. The application was filed on September 20, 2023, by inventors Daniel E. Johnson and Jennifer R. Grandis.
Composition for Regulating Interfering Ribonucleic Acid Production
The USPTO has published a new patent application (US20260085312A1) detailing compositions and methods for regulating interfering ribonucleic acid (miRNA) production. The application describes techniques to decrease the bioavailability of target biomolecules by degrading or inactivating their corresponding messenger RNA (mRNA).
USPTO Patent Application for Modulating SMN2 RNA and Protein
The USPTO has published a patent application (US20260085313A1) detailing compounds, methods, and pharmaceutical compositions for modulating SMN2 RNA and protein. This application, filed on May 2, 2025, aims to ameliorate symptoms of neurodegenerative disorders.
Conjugated Oligonucleotide Compounds for Therapeutic Use
The USPTO has published a new patent application (US20260085314A1) for conjugated oligonucleotide compounds, methods of making them, and their therapeutic uses. The application was filed on May 16, 2025, by inventors Ahmad Ali Mortazavi, Viviana Mannella, and Muthusamy Jayaraman.
HMBOX1 Inhibitor for Muscle Atrophy Treatment
The USPTO has published a patent application (US20260085316A1) from Shanghai University detailing the use of a homeobox containing 1 (HMBOX1) inhibitor for the prevention and treatment of muscle atrophy. The application outlines findings from cellular and animal studies supporting the therapeutic potential of inhibiting HMBOX1 expression.
siRNA for AGT gene expression inhibition in hypertension treatment
The USPTO has published a new patent application (US20260085317A1) detailing modified oligonucleotide sequences designed as siRNAs to inhibit angiotensinogen (AGT) gene expression. The application suggests these siRNAs may be used in the development of treatments for hypertension and related diseases.
WA DOH Revokes, Suspends Health Care Provider Licenses
The Washington State Department of Health has indefinitely suspended the credentials of two health care providers, Reshawn Bernard Hayes and Hinda Ahmed Mohamed, in March 2026. These actions follow arrests, guilty pleas to domestic violence offenses, and alleged financial misconduct.
Washington State Disciplines Health Care Providers
The Washington State Department of Health has taken disciplinary actions against several health care providers in March 2026. Actions include charges of unprofessional conduct, denial of applications, and termination of probation, impacting providers across various counties.
Patent Application: Monitoring User Emotional States from Devices
The USPTO has published a patent application (US20260083370A1) detailing methods for monitoring, tracking, and reporting user emotional states from a managed device. The application describes systems that analyze communication and operational data to determine emotional patterns and transmit reports to a managing device, potentially triggering alerts for negative emotional states.
Patent Application: Cognitive Load Adaptation in Mobile AI
The USPTO has published a patent application from International Business Machines Corporation for a system that adapts mobile AI content generation based on a user's cognitive load. The application, filed on September 23, 2024, aims to ensure generated content keeps the user's cognitive load within a desired threshold.
US patent application for wearable mental disorder diagnosis system
US patent application for wearable mental disorder diagnosis system
Patent Application: Reducing Fasting Blood Glucose Using Plants
The USPTO has published a new patent application detailing methods and compositions for reducing fasting blood glucose using plants like Dichrostachys glomerata or Cissus quadrangularis. The application, filed on September 26, 2024, describes oral dosage forms for health benefits including increased GLP-1 levels and reduced blood lipids.
Patent Application: Reducing Visceral Fat Using Plants and Spices
The USPTO has published a new patent application (US20260083810A1) detailing methods and compositions for reducing visceral fat in mammals using plants and spices such as Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is scheduled for publication on March 26, 2026.
Patent Application: Reducing Blood Lipids Using Plants
The USPTO has published a patent application (US20260083811A1) detailing methods and compositions for reducing blood lipids using plants like Dichrostachys glomerata or Cissus quadrangularis. The application, filed on September 26, 2024, describes compositions aimed at increasing GLP-1 levels and reducing visceral fat, food intake, blood lipids, total cholesterol, and total glucose.
Patent Application: Reducing Food Intake Using Plants
The USPTO has published a new patent application (US20260083809A1) detailing methods and compositions using plants like Dichrostachys glomerata or Cissus quadrangularis to reduce food intake or appetite in mammals. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.
Antiviral Fungal Extracts Prevent Coronavirus Infections
The USPTO has published a patent application (US20260083788A1) detailing antiviral fungal extracts that may prevent coronavirus infections by interfering with the Spike protein. The application, filed by Mycotech Pharma AS, describes compositions derived from Agaricus blazei, Grifola frondosa, and Hericium erinaceus.
US Patent Application for Heart Boosting Formulation
The USPTO has published a new patent application (US20260083806A1) for a heart boosting formulation. The application details a specific composition including L-carnitine, alpha-linolenic acid, citrulline, vitamin D3, lycopene, holy basil, cinnamon, and beetroot, along with related manufacturing methods. The filing date was September 16, 2025.
Patent Application for Dichrostachys glomerata to Reduce Anxiety and Improve Mood
The USPTO has published a patent application (US20260083797A1) detailing methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, and stress, and to improve mood, energy, and overall health in mammals. The application was filed on September 26, 2024.
Patent Application for Dichrostachys glomerata to Reduce Anxiety and Stress
The USPTO has published a new patent application (US20260083796A1) detailing methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, and food cravings, while improving mood and overall health in mammals. The application was filed on September 26, 2024, by inventor Shil Kothari.
Patent Application for Dichrostachys glomerata Health Benefits
The USPTO has published a patent application (US20260083794A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety and improving mood. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.
Patent Application: Dichrostachys glomerata for Anxiety and Stress Reduction
The USPTO has published a patent application (US20260083793A1) detailing methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, and food cravings, while improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.
Patent Application for Dichrostachys glomerata to Reduce Anxiety and Cravings
The USPTO has published a new patent application (US20260083792A1) for methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, food cravings, and improve mood and overall health. The application was filed on September 25, 2024, by inventor Shil Kothari.
Patent Application: Dichrostachys glomerata Health Benefits
The USPTO has published a patent application (US20260083791A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety, food cravings, and stress, and improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.
Formulation for Hair Growth
The USPTO has published a new patent application, US20260083789A1, for a formulation designed to stimulate hair growth and improve hair quality. The formulation primarily utilizes a nitrate-enriched extract of Amaranth, along with other plant-based ingredients. The application details the method of preparation and its potential use in enhancing hair growth rate, count, and density.
GABA-producing bacteria for improving health patent application
The USPTO has published a new patent application (US20260083786A1) detailing a composition comprising Lactobacillus brevis (NCIMB 41903) for use in regulating or treating metabolic diseases. The application was filed on September 17, 2025, by inventors Paul Ross and Catherine Stanton.
Patent Application: Bifidobacterium longum for Infant Infection Prevention
The USPTO has published a patent application (US20260083785A1) detailing the use of Bifidobacterium longum transitional microorganisms to prevent or reduce the risk of infection in infants and young children. The application was filed on September 27, 2023.
Patent Application for Cancer Treatment Combination Therapies
The USPTO has published a new patent application (US20260083816A1) detailing methods for treating cancer using combination therapies. The application, filed by inventors Erlinda M. Gordon and Fredrick L. Hall, focuses on inhibiting cyclin proteins and targeting pathways that promote cyclin activity.
USPTO Patent Application for Dietary Supplement Formulation
The USPTO has published a patent application (US20260083814A1) for a dietary supplement formulation designed to alleviate sciatica pain and support nerve and musculoskeletal health. The application details a specific blend of natural ingredients and their purported benefits, filed on September 26, 2024.
Patent Application for Reducing DPP-4 Activity with Plants
The USPTO has published a new patent application (US20260083813A1) detailing methods and compositions using plants like Dichrostachys glomerata or Cissus quadrangularis to reduce DPP-4 activity or levels in mammals. The application was filed on September 26, 2024.
FDA Complaint Document Details
The Food and Drug Administration (FDA) has posted details regarding a complaint document, with the information made available on March 26, 2026. The document is related to the Center for Tobacco Products (CTP) and is available for download.
FDA CDRH Variance Approval Letter to Axion Laser
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Axion Laser. This document grants a specific variance, indicating an approved deviation from standard regulatory requirements for a particular product or process.
FDA Final Response Letter to Athyna Pharma LLC
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has issued a final response letter to Athyna Pharma LLC. This document provides specific feedback and guidance related to the company's pharmaceutical development or regulatory submissions.
FDA Variance Request from Laina Callow - Comment Period Closed
The Food and Drug Administration (FDA) has closed the comment period for a variance request submitted by Laina Callow. The application, authored by CDRH, was available for public comment on regulations.gov.
FDA Acknowledges Letter to DePaul University
The Food and Drug Administration (FDA) has acknowledged receipt of a letter from DePaul University's Idea Realization Laboratory. This notice serves as an acknowledgment of the correspondence, with no further regulatory action or guidance provided at this time.
FDA Acknowledgement Letter to Premier Research International, LLC
The Food and Drug Administration (FDA) has issued an acknowledgement letter to Premier Research International, LLC. This notice confirms receipt of a submission, though no specific details about the submission's content or regulatory implications are provided.
FDA CDER Final Response Letter to Age Reversal Unity
The FDA's Center for Drug Evaluation and Research (CDER) has issued a final response letter to Age Reversal Unity regarding their submissions. The document is available through the Regs.gov portal.
FDA Acknowledgment Letter to Laina Callow
The Food and Drug Administration (FDA) has issued an acknowledgment letter to Laina Callow regarding a submission. The document is a redacted version of an acknowledgment letter from the FDA's Division of Management and Budget (DMB) to Laina Callow, authored by CDRH.
Citizen Petition Filed by Premier Research International LLC
Premier Research International LLC has filed a citizen petition with the Food and Drug Administration (FDA) regarding regulatory matters. The petition is available for public review and comment.
FDA Variance Application from Ingram Planetarium
The Food and Drug Administration (FDA) has posted a variance application from Ingram Planetarium. The application is available for review on Regulations.gov, with the author listed as CDRH.
FDA Acknowledgment Letter to Axion Laser
The Food and Drug Administration (FDA) has issued an acknowledgment letter from its Division of Management and Budget (DMB) to Axion Laser. This notice confirms receipt of a submission, though no specific details about the submission's content or purpose are provided in the available information.
FDA Decision on Tradipitant New Drug Application Refusal
The Food and Drug Administration (FDA) has issued a final decision regarding the new drug application for Tradipitant. The agency has decided to refuse to approve the application, based on a proposal to do so. The specific details of the decision are confidential business information, but a redacted version is available.
FDA Variance Approval Letter to Dapper Rave, LLC
The Food and Drug Administration (FDA) has issued a variance approval letter to Dapper Rave, LLC, through its Center for Devices and Radiological Health (CDRH). This document signifies an approval for a specific variance requested by the company.
FDA Variance Approval Letter
The Food and Drug Administration (FDA) has issued a variance approval letter to Laina Callow. The letter, originating from the Center for Devices and Radiological Health (CDRH), indicates a specific approval related to a medical device or process. A redacted version is available for public review.
FDA Variance Amendment from DePaul University Idea Realization Laboratory
The Food and Drug Administration (FDA) has posted a variance amendment submitted by DePaul University's Idea Realization Laboratory. The document is available for review on the Regs.gov platform, with an associated attachment from the Center for Devices and Radiological Health (CDRH).
DePaul University Variance Application
The FDA has posted a variance application submitted by DePaul University's Idea Realization Laboratory. The document is available for review on the Regs.gov platform. No specific compliance actions or deadlines are indicated for other entities.
FDA Complaint Document - Closed for Comments
The Food and Drug Administration (FDA) has opened a public comment period for a new complaint document, identified by docket number FDA-2026-H-2944. The comment period is scheduled to close on March 26th.
FDA Completeness Assessment Correspondence
The Food and Drug Administration (FDA) has posted Completeness Assessment Correspondence related to drug applications. This notice indicates that documentation is available for review via the provided URL, though no specific documents are directly viewable or downloadable from the initial posting.
FDA Variance Approval Letter to DePaul University
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to DePaul University's Idea Realization Laboratory. This document signifies approval for a specific variance related to medical device development or testing.
FDA Variance Application from Axion Laser
The Food and Drug Administration (FDA) has posted a variance application from Axion Laser. This document is available for review on the FDA's regulations.gov portal.
FDA Acknowledgment Letter to Ingram Planetarium
The Food and Drug Administration (FDA) has issued an acknowledgment letter to Ingram Planetarium regarding a submission. The letter, dated March 26, 2026, confirms receipt of documentation from the Center for Devices and Radiological Health (CDRH). No specific details about the submission's content or regulatory implications are provided.
Patent Application: Vaccine for Bordetella pertussis using antigen peptides
The USPTO has published a patent application (US20260083833A1) for a vaccine against Bordetella pertussis using antigen peptides. The application details a method for preventing infection by targeting specific peptides processed and presented by CD4+ T cells. This relates to ongoing research and development in vaccine technology.
Immune Cells Target EpCAM for Tumor Treatment
The USPTO has published a patent application (US20260083843A1) from SUZHOU IMMUNOHEAD BIOTECHNOLOGY CO., LTD. The application details the use of immune cells that target EpCAM for the prevention or treatment of metastatic tumors expressing EpCAM.
Cellicure, Inc. Patent Application for Engineered Immune Cells
The USPTO has published a patent application (US20260083845A1) filed by Cellicure, Inc. on September 22, 2023. The application details engineered immune cells, specifically chimeric antigen receptors (CARs) for enhanced killing activities, primarily targeting cancer treatment.
USPTO Patent Application: Polynucleotides Targeting NR4A3
The USPTO has published a patent application (US20260083846A1) filed by Lyell Immunopharma, Inc. The application describes polynucleotides designed to target the NR4A3 gene and their potential use in treating diseases, including cancer. The patent is scheduled to be published on March 26, 2026.
Patent for Radiation Dose Enhancement and Tumor Delineation
The USPTO has published a new patent application (US20260083850A1) for compounds, compositions, and methods related to radiation dose enhancement and tumor delineation. The application, assigned to the University of Connecticut, focuses on using barium nanoparticles for improved radiation therapy and tumor identification.
Proteoglycan Mimetics for Wound Healing and Angiogenesis
The USPTO has published a new patent application, US20260083852A1, detailing proteoglycan mimetics for enhanced wound healing and angiogenesis. The application describes compounds designed to support tissue regeneration and promote vascular repair, potentially limiting systemic exposure to VEGF activity.
USPTO Patent for Therapeutic Compounds Treating Cancer
The USPTO has published patent application US20260085059A1 for therapeutic compounds and methods of use in treating cancer. The patent was assigned to Servier Pharmaceuticals LLC and lists Samuel V. Agresta et al. as inventors. The application was filed on May 7, 2025.
Chemical Compound with Triazine Group and Production Method
The USPTO has published a patent application (US20260085087A1) for a chemical compound comprising a triazine group and its production method. The application relates to novel nucleotides and oligonucleotides with modified phosphate groups, potentially useful in diagnostics, gene therapy, and treating bacterial and viral diseases, including COVID-19.
CAR T-cell therapy combined with BTK inhibitors for cancer
The USPTO has published a new patent application (US20260083848A1) detailing a combination therapy for cancer treatment. The application describes the use of CAR T-cell therapy with BTK inhibitors for treating hematological malignancies. This represents a new disclosure in the field of cancer therapeutics.
Modified T-Cells for Bladder Cancer Treatment Application
The USPTO has published a patent application (US20260083849A1) detailing a method for treating bladder cancer using modified immunoresponsive cells. The application was filed on September 7, 2023, and is related to therapeutic applications in oncology.
Antimicrobial Compositions Patent Application
The USPTO has published a patent application (US20260083126A1) for antimicrobial compositions containing organosulfur compounds. The application, filed on September 8, 2023, describes compounds useful for treating microbial infections and for cleaning, disinfecting, or agricultural use.
Patent Application: T-cell receptors target mutant RAS for cancer treatment
The USPTO has published patent application US20260083847A1 concerning T-cell receptors and compositions for treating cancer associated with mutant RAS. The application details methods and compositions involving T-cell receptors that bind to specific mutant RAS peptide fragments in the context of specific HLA types.
Meloxicam Pharmaceutical Composition and Application
The USPTO has published a patent application (US20260083748A1) for a pharmaceutical composition containing meloxicam, a composite solvent, and an acidic pH regulator. The assignee is Beijing Tide Pharmaceutical Co., Ltd. This application details a preparation method and its application, focusing on a formulation that avoids organic solvents for increased safety and reduced environmental impact.
Adjuvant Composition with STING Agonist and Aluminium Hydroxide
The USPTO has published a patent application by GlaxoSmithKline Biologicals SA for an adjuvant composition comprising a STING agonist and an aluminum-based adjuvant. The application details immunogenic compositions and their use in immunizing subjects.
Cancer Treatment Using TTFields and Interferon Gamma Compositions
The USPTO has published a new patent application detailing compositions, systems, and methods for treating cancer using Tumor Treating Fields (TTFields) in combination with interferon gamma. The application, filed on September 18, 2025, outlines a method for reducing cancer cell viability and tumor volume.
Patent Application: Autism Symptom Treatment via Neurotensin Receptor Activation
The USPTO has published a new patent application (US20260083820A1) from the New York Institute of Technology for methods and formulations to treat autism symptoms by activating neurotensin receptor 1 (NTSR1) without causing significant lethargy. The application was filed on October 3, 2025.
Ocular Insulin Delivery Enhanced by Prostaglandin Analogues Patent Application
The USPTO has published a patent application (US20260083822A1) for a novel ocular insulin delivery system. The invention utilizes prostaglandin analogues to enhance insulin permeability across ocular tissues, offering a non-invasive alternative to injections for therapeutic effects.
Patent Application for Biodegradable Particles Delivering Therapeutic Agents
The USPTO has published a new patent application (US20260083830A1) for biodegradable polymeric particles designed for the extended, controlled release of positively charged therapeutic agents at neutral pH. The application details microparticles and nanoparticles comprising an uncapped polymer matrix and a net positively charged therapeutic agent.
Wound healing composition with amino acids and fish collagen
The USPTO has published a new patent application detailing a composition for promoting wound healing. The composition includes an amino acid mixture and fish collagen, with a method for its administration also described. This application was filed on September 20, 2024.
USPTO Patent Application for WNT-Related Cancer Vaccines
The USPTO has published a patent application (US20260083831A1) filed by Geneos Therapeutics, Inc. The application details compositions and methods for treating WNT-related cancers using nucleic acid sequences encoding tumor-specific antigens, potentially in combination with checkpoint inhibitors.
Patent Application for DNase Enzyme Therapy for Tumor Microenvironment Immunomodulation
The USPTO has published a patent application (US20260083827A1) filed by CLS THERAPEUTICS LIMITED for methods of immunomodulating the tumor microenvironment using DNase enzyme therapy. The application details methods involving the administration of DNase enzyme, alone or with other agents, to combat immunosuppressive tumor cell microenvironments.
Novel agent for Alzheimer's treatment using dynamin 1 peptide
The USPTO has published a new patent application (US20260083826A1) from the Okinawa Institute of Science and Technology School Corporation for a novel agent to treat Alzheimer's disease. The application describes a peptide corresponding to dynamin 1, potentially encapsulated in nanoparticles for improved brain delivery.
Genetically Modified Clostridium Acetobutylicum for Lignocellulosic Biomass
The USPTO has published a patent application (US20260085278A1) detailing genetically modified Clostridium acetobutylicum strains designed for efficient growth on lignocellulosic biomass. The application, filed by Institut National des Sciences Appliquees de Toulouse, describes overexpressing specific operons to enhance biomass conversion for producing bulk chemicals like ethanol and butanol.
GalNAc Monomer for Liver-Targeted Nucleic Acid Drug Delivery
The USPTO has published a patent application detailing a GalNAc monomer for liver-targeted delivery of small nucleic acid drugs. The application, filed by inventors Zeao Huang et al., describes a compound that enhances drug efficacy through efficient liver targeting.
Patent Application: Iron Metabolism Targets for Obesity Treatment
The USPTO has published a new patent application (US20260085321A1) detailing methods for treating obesity by inhibiting specific iron metabolism genes. The application, filed on September 24, 2025, by inventor Richard Possemato, proposes inducing weight loss through increased lipid catabolism.
Engineered Ketoreductases for Chiral Alcohol Preparation
The USPTO has published a patent application (US20260085334A1) for engineered ketoreductase polypeptides developed by Enzymaster (Ningbo) Bio-Engineering Co., Ltd. The patent describes enzymes capable of preparing chiral alcohols with high catalytic activity, stereoselectivity, thermal stability, and solvent tolerance.
Method for Producing Oil Composition via Biomass Fermentation
The USPTO has published a patent application detailing a method for producing an oil composition through the fermentation of biomass using specific yeast strains. The application outlines a preparation stage, a fermentation stage with controlled temperature and pH, and an oil procurement stage involving mechanical cell lysis.
Patent Application for Metabolism Disease Therapeutic Agents
The USPTO has published a new patent application (US20260085322A1) for therapeutic agents targeting metabolism-associated diseases, such as MAFLD. The application was filed on September 6, 2023, by inventors from the USPTO.
Patent Application for Plant Regulatory Elements and Uses
The USPTO has published a patent application (US20260085324A1) detailing novel synthetic small nuclear RNA (snRNA) promoters for CRISPR-mediated gene modifications in plants. The application, filed on October 3, 2025, includes methods and compositions for developing plants with modified genomes using these promoters.
Patent Application for Pseudomonas Recombinant Protein Expression
The USPTO has published a new patent application, US20260085338A1, detailing a Pseudomonas sp. strain for recombinant protein expression. The application was filed on September 6, 2023, and relates to novel expression systems for biotechnological applications.
Method for Detecting Polynucleotide Analyte Using CRISPR/Cas Effector
The USPTO has published a new patent application detailing a method for detecting polynucleotide analytes using CRISPR/Cas effector technology. The application, filed by inventors from USPTO, describes a method involving a cleaving agent with flap endonuclease activity and a type V CRISPR/Cas effector protein, specifically a Cast2 protein.
Patent Application: Disruption of GROOT Gene Function Increases Plant Biomass
The USPTO has published a patent application (US20260085325A1) from the Salk Institute for Biological Studies detailing methods to enhance plant biomass and seed size by reducing the expression of GROOT1, GROOT2, and GROOT3 genes. The application describes compositions and transformed plants generated using these methods.
Viral Protein Expression Patent Application
The USPTO has published a new patent application, US20260085328A1, filed on September 8, 2023. The application describes methods and systems for producing adeno-associated virus (AAV) particles using insect cells.
Methods for rapid multiplex HLA genotyping and transcript quantitation
The USPTO has published a new patent application detailing methods for rapid multiplex HLA genotyping and transcript quantitation using nanopore technology. The application, assigned to The University of North Carolina at Chapel Hill, outlines techniques for determining HLA status and genotyping donor cells for transplantation.
Breast Cancer Detection Kit, Device, and Method Patent Application
The USPTO has published a patent application (US20260085359A1) from TORAY INDUSTRIES, INC. for a breast cancer detection kit, device, and method. The application describes a kit or device comprising nucleic acids that specifically bind to a miRNA in a subject's sample, and a method for detecting breast cancer by measuring the miRNA in vitro.
US Patent Application for PDCD1 Knockout RNA Molecule
The USPTO has published a new patent application (US20260085331A1) for an RNA molecule designed for biallelic knockout of PDCD1. The application, filed on September 18, 2023, details compositions comprising RNA molecules with specific guide sequences and their methods of use.
Alpha-amylase variants and polynucleotides patent application
The USPTO has published a new patent application, US20260085261A1, from Novozymes A/S concerning alpha-amylase variants and related polynucleotides. The application details specific molecular constructs and their potential uses.
Chimeric Transposases and Fusion Proteins Patent Application
The USPTO has published a new patent application (US20260085332A1) detailing chimeric transposases and fusion proteins. The application, filed on October 3, 2025, by inventors Joseph S. Lucas, Blair B. Madison, and Olga Batalov, covers polynucleotides, vectors, and methods for modifying cells using these proteins.
USPTO patent application for bioprocess on cell cultures
The USPTO has published a patent application (US20260085266A1) detailing a method for performing a bioprocess on liquid immune or naive cell cultures. The application, filed on December 13, 2022, describes an integrated bioprocessing system with preconfigurable cartridges for cell therapy.
Electroporation Apparatus and Methods Patent Application
The USPTO has published a patent application (US20260085268A1) filed by MaxCyte, Inc. on September 6, 2023. The application describes an apparatus and methods for electroporation of cells, including safety features like an emergency stop button. This is a new patent application and does not impose new regulatory requirements.
Patent Application for Fermentation Process Standardization
The USPTO has published a patent application (US20260085274A1) from Precision Fermentation, Inc. The application details methods and systems for standardizing fermentation processes, including constructing baseline databases and initiating new process instances. This is a new patent application filing.
Patent Application for Mycelium Substrate Preparation
The USPTO has published a new patent application (US20260085276A1) detailing means and methods for preparing a mycelium-colonized substrate. The application, filed on September 25, 2023, describes a method involving incubating a substrate with synthetic granulometry regulators and a solid-state mycelium bioreactor.
Patent Application for Microorganism and Ergothioneine Production
The USPTO has published a patent application (US20260085277A1) from Kureha Corporation detailing a novel microorganism and a method for producing ergothioneine. The application includes specific microorganism accessions and CPC classifications related to biotechnology and chemical synthesis.
Corynebacterium Mutant Strain for Enhanced L-Arginine or L-Citrulline Productivity
The USPTO has published a patent application by Daesang Corporation for a Corynebacterium mutant strain designed for enhanced L-arginine or L-citrulline productivity. The application details a method for producing these amino acids using the modified strain, which exhibits increased activity in the L-arginine biosynthesis pathway.
Patent Application for Modified Microorganisms Consuming Xylose
The USPTO has published a patent application (US20260085280A1) for methods of modifying microorganisms to increase xylose consumption. The application, filed by MARA RENEWABLES CORPORATION, details processes for enhancing microbial growth on hemicellulosic carbohydrates.
Patent Application: Culture Medium Production Using Microbial Co-Hydrolysis
The USPTO has published a patent application (US20260085281A1) detailing a method for producing culture medium through microbial co-hydrolysis of plant proteins. The application, filed on April 10, 2025, aims to improve soil and cultivation effects using waste seasoning.
Patent Application for On-Board Lysis Capsule in Fluidic Cartridge
The USPTO has published a patent application (US20260085275A1) for an on-board lysis capsule designed for fluidic cartridges. The capsule contains beads and magnetic elements for cell lysis and may include an internal control for assay validation. The application was filed by Gen-Probe Incorporated.
Stem cell-derived gastruloid model and construction method
The USPTO has published a patent application detailing a stem cell-derived gastruloid model and its construction method. This model simulates early embryonic development and can be used for drug screening and safety testing, particularly for early pregnancy applications.
Methods for Producing Retinal Pigment Epithelium Cells
The USPTO has published a new patent application detailing methods for producing retinal pigment epithelium (RPE) cells. The application describes specific culturing and replating techniques using laminin substrates to expand and mature RPE cells for potential therapeutic uses.
Anti-tumor immune response enhancer patent application
The USPTO has published a new patent application, US20260085286A1, detailing an 'Anti-tumor immune response enhancer'. The application, filed by Kenichiro Hasumi, describes a composition comprising phospholipids to enhance anti-tumor activity and induce cytokine production.
Therapeutic Macrophages Patent Application
The USPTO has published a patent application (US20260085287A1) filed by Resolution Therapeutics Limited for therapeutic macrophages genetically engineered to overexpress Interleukin-10 (IL-10) or IL-10 in combination with Matrix Metallopeptidase 9 (MMP9). This application relates to potential treatments for inflammatory conditions.
Patent Application: Method of Differentiating Pluripotent Stem Cells to Hematopoietic Cells
The USPTO has published a patent application (US20260085288A1) detailing a method for differentiating pluripotent stem cells into hematopoietic precursor and stem cells. The application, filed by Boris Greber and Daniel Terheyden-Keighley, outlines a process using specific induction cocktails for generating immune cells like NK cells.
Enzyme-containing article with water barrier properties
The USPTO has published a new patent application, US20260085163A1, detailing an enzyme-containing biodegradable single-layer article with water barrier properties. The application was filed by Vincent Legrand and includes various CPC classifications related to polymers and enzymes.
Ovarian and Uterine Organoid Production and Pharmaceutical Screening
The USPTO has published a patent application detailing methods for producing ovarian and uterine organoids from stem cells. These organoids are intended for use in screening pharmaceutical interventions for diseases and for applications in hormone replacement therapy and assisted reproduction technologies.
Viscoelastic Hydrogel Regulates Organoid Patterning and Vascularization
The USPTO has published a new patent application, US20260086081A1, detailing a viscoelastic hydrogel for regulating organoid patterning and vascularization. The application, filed on April 10, 2025, describes spinal cord models using methacrylated hyaluronic acid and dopamine-modified hyaluronic acid.
Viscoelastic Hydrogel Regulates Organoid Patterning and Vascularization
The USPTO has published a new patent application, US20260086082A1, detailing a viscoelastic hydrogel for regulating organoid patterning and vascularization. The application, filed by inventors Changchun Zeng, Yan Li, and Xingchi Chen, focuses on a spinal cord model.
Cardio-Tox TEEM Model for Cardiotoxicity and Arrhythmia Risk Assessment
The USPTO has published a patent application detailing the Cardio-Tox Tissue Engineered Model (TEEM). This in vitro model uses 3D human heart microtissues to assess cardiotoxicity and arrhythmia risk from test compounds, aiming to establish safe human exposure levels for environmental and pharmaceutical substances.
Patent Application for Cell Manipulation Device and Method
The USPTO has published a new patent application (US20260086001A1) for a cell manipulation device and method. The application, filed on December 1, 2025, describes a technique for culturing cells by attaching them to an air bubble formed in a liquid flow path. This is a routine publication of a patent application.
Patent Application for mRNA Design
The USPTO has published patent application US20260088125A1 concerning methods for designing synthetic RNA molecules, specifically for mRNA design. The application details a process for obtaining coding sequences and selecting regions for synthetic RNA molecule production.
Method Predicts Prime Editing Efficiency in Different Cell Types
The USPTO has published a patent application (US20260088126A1) detailing a method and device for predicting prime editing efficiency in various cell types and prime editor types. The application, filed by Yonsei University, focuses on training predictive models for both on-target and off-target prime editing efficiency.
Delayed Harvest Methods for Short Stature Corn Plants
The USPTO has published a patent application (US20260083046A1) detailing methods for delayed harvesting of short stature corn plants. The application, filed on October 23, 2025, aims to provide growers with a flexible harvesting window to optimize drying or seed access without increasing yield loss risk.
Coffee Fermentation Using Pichia Kluyveri and Lactiplantibacillus Plantarum
The USPTO has published a patent application (US20260083149A1) from CHR. HANSEN A/S detailing a method for coffee fermentation using specific yeast and bacteria strains. The application focuses on improving coffee bean and beverage production through controlled fermentation processes.
Edible Aerial Mycelium Patent Application
The USPTO has published a patent application (US20260083160A1) filed on November 5, 2023, for edible aerial mycelium, methods of preparation, and food products containing them. The application includes hybrid food products with aerial mycelium and meat.
Patent Application: Complex for Cartilage Differentiation
The USPTO has published a new patent application (US20260083780A1) detailing a complex for promoting cartilage differentiation. The application describes a method for fabricating cartilage and a pharmaceutical composition for treating arthropathy, filed on June 2, 2025.
Antimicrobial use of Micrococcus porci against Staphylococcus species
The USPTO has published a patent application detailing the selective antimicrobial use of Micrococcus porci against harmful Staphylococcus species. The application describes compositions comprising Micrococcus porci for use in cosmetics, quasi-drugs, external skin preparations, or medicines.
Patent Application for Engineered Bacteriophage Transducing Particles Production
The USPTO has published a new patent application (US20260083787A1) from TROBIX BIO LTD. for systems and methods for producing engineered bacteriophage transducing particles. The application details novel approaches for manipulating bacterial populations using these particles and associated regulatory elements.
Patent Application for Treating DNAse1 Deficiency Diseases
The USPTO has published a new patent application (US20260083828A1) detailing compositions and methods for treating diseases associated with DNAse1 and/or DNAse1L3 deficiency. The application was filed on September 11, 2025, by inventors Demetrios Braddock, Paul Stabach, and Ethan Lester.
Patent Application: Alpha-Glucosidase Compositions for Pompe Disease Treatment
The USPTO has published a new patent application (US20260083829A1) from Amicus Therapeutics, Inc. The application details compositions comprising high concentrations of acid alpha-glucosidase and active site-specific chaperones for treating Pompe disease. It also covers methods for increasing enzyme stability.
mRNA Vaccine and Immune Modulator Combination Patent Application
The USPTO has published a patent application (US20260083837A1) for a combination comprising mRNA molecules for vaccines or therapeutic proteins, along with immune-modulating mRNA. The application details combinations for improved or reduced immunogenicity to increase efficacy, and relates to host cells, pharmaceutical compositions, vaccines, and kits for medical use.
Patent Application: Conditioned Media, Cultured Cells Production
The USPTO has published a new patent application, US20260083818A1, detailing a system and method for the production, formulation, and use of conditioned media and cultured cells. The application was filed on May 7, 2025, and describes techniques for culturing various cell types, including animal and plant cells, together.
CRISPR/Cas13a Kit for Rapid ALV-J Detection
The USPTO has published a patent application for a CRISPR/Cas13a kit designed for the rapid detection of avian leukosis virus subgroup J (ALV-J). This application details a method combining CRISPR/Cas13a with recombinase aided amplification for improved sensitivity and specificity in detecting ALV-J.
Use of G007-LK for Osteogenic Differentiation and Bone Regeneration
The USPTO has published patent application US20260085289A1, detailing the use of a compound known as G007-LK. The application, filed by the Hospital of Stomatology, Guangzhou Medical University, describes G007-LK's potential to promote osteogenic differentiation of dental stem cells and aid in bone tissue regeneration.
Patent Application for Feeder Cells and Cell Sheet Production
The USPTO has published a new patent application (US20260085290A1) filed by DAI NIPPON PRINTING CO., LTD. The application details a method for producing feeder cells and cell sheets, derived from pluripotent stem cells, intended for maintaining or proliferating difficult-to-culture cells. This is a standard publication of a patent application.
Patent Application: Diabetes Prevention/Treatment by Myeloid Suppressor Cell Activity
The USPTO has published a new patent application (US20260085291A1) from CREATIVE MEDICAL TECHNOLOGIES, INC. The application details methods and compositions for preventing or treating Type 1 diabetes by augmenting myeloid suppressor cell activity, potentially involving conditioned immune cells or exogenous suppressor cells.
Minimal Essential Media for Human Induced Pluripotent Stem Cells
The USPTO has published a patent application (US20260085292A1) detailing minimal essential media for culturing human induced pluripotent stem cells (iPSCs). The application was filed on September 11, 2023, by inventor Paul Wesley Burridge.
USPTO Patent Application for Body Fluid Sample Transport Solution
The USPTO has published a new patent application (US20260085293A1) detailing a solution and method for transporting or storing body fluid samples. The application, filed on March 27, 2024, by inventors Mitsumi NISHI, Noriko MIYAUCHI, and Rieko SHIMAMURA, describes a solution containing specific active ingredients for sample preservation.
Process for Producing Purified Rhabdovirus from Cell Culture
The USPTO has published a patent application detailing a process for producing a purified rhabdovirus from cell culture, specifically oncolytic rhabdoviruses like vesicular stomatitis virus. The application, filed on August 21, 2025, outlines methods for both upstream and downstream processing.
Patent Application for AAV Purification Using Anion Exchange Chromatography
The USPTO has published a patent application (US20260085295A1) detailing methods for purifying adeno-associated viruses (AAV) using anion exchange chromatography. The application, filed on September 23, 2025, by inventors Garima Thakur, Sheldon Robert Mink, and Andrew David Tustian, focuses on enhancing purification efficiency and concentration.
Bacterial Superoxide Dismutases Patent Application
The USPTO has published a patent application (US20260085297A1) filed by Novozymes A/S for bacterial superoxide dismutases. The application, filed on August 29, 2025, describes polypeptides useful in animal feed additives for improving growth, performance, and health.
Method for Efficient Biosynthesis of Rebaudioside M2 Using Glycosyltransferase
The USPTO has published a patent application detailing a method for the efficient biosynthesis of rebaudioside M2 using glycosyltransferase. The assignee, GUILIN LAYN NATURAL INGREDIENTS CORP., claims this method provides an environmentally friendly way to produce rebaudioside M2 with no by-products, potentially reducing production costs.
Patent Application for Engineered Pyrococcus Enzymes
The USPTO has published patent application US20260085299A1 for engineered Pyrococcus enzymes designed for improved nucleotide analogue incorporation in DNA sequencing. The application was filed on May 27, 2025.
Patent Application: Genome Modification Compositions and Methods
The USPTO has published a new patent application (US20260085301A1) from Confluence Genetics, LLC, detailing compositions and methods for targeting and eliminating cells with pre-determined DNA sequences using Cas12a2 protein. The application was filed on September 19, 2025.
Method to enhance CAR-T cell efficacy using NOS inhibitor
The USPTO has published a patent application (US20260083844A1) detailing a method to enhance CAR-T cell efficacy by downregulating nitric oxide synthase (NOS). This application describes a potential therapeutic approach for treating B cell malignancies that are resistant to current CAR-T cell treatments.
Patent Application: Plant Pest Control using Cas12a2 Protein
The USPTO has published a patent application (US20260085302A1) from Confluence Genetics, LLC, detailing methods and compositions for controlling plant pests using Cas12a2 protein and guide polynucleotides. The application describes targeting specific DNA or RNA sequences within plant pests for elimination.
Novel cell wall hydrolases target Cutibacterium acnes conditions
The USPTO has published a patent application (US20260085303A1) detailing novel cell wall hydrolases designed to target Cutibacterium acnes. The application describes compositions and uses for treating conditions associated with this bacterium.
Methods for adding polymers to ribonucleic acids
The USPTO has published a patent application detailing methods for adding polymers of non-canonical nucleotides to the 3' end of ribonucleic acids (RNA). The application, filed by inventors from institutions including the University of California, describes techniques that may be used for RNA analysis and identification. This publication represents a new patent application and does not impose immediate regulatory obligations.
Patent Application for Nucleic Acid Library Preparation
The USPTO has published a new patent application, US20260085306A1, detailing ligation-free methods for preparing nucleic acid libraries for high-throughput sequencing. The application was filed on January 16, 2024, and published on March 26, 2026.
Genome-wide insulator screening system disclosed
The USPTO has published a patent application detailing a genome-wide insulator screening system. The system, comprising specific MAI-seq vectors, is designed for high-sensitivity screening of genomic insulators and is applicable to any species.
Methods for Generating cDNA Library from RNA
The USPTO has published a patent application (US20260085308A1) detailing methods for the fast and efficient generation of cDNA libraries from RNA. The application, filed on September 11, 2023, by inventors Keith Brown, Steven Head, and Phillip Ordoukhanian, describes a method adaptable for automation.
Patent Application: Compositions for Treating CHD2 Haploinsufficiency
The USPTO has published a patent application (US20260085319A1) for compositions and methods to treat CHD2 haploinsufficiency. The application details a method of increasing Chromodomain Helicase DNA Binding Protein 2 (CHD2) in neuronal cells using a nucleic acid agent.
Method for Trans-Differentiating Non-Neuronal Cells into Neurons
The USPTO has published a patent application (US20260085284A1) from SHANGHAI GENEMAGIC BIOSCIENCES CO., LTD. for a method of trans-differentiating non-neuronal cells into neurons using specific regulators. The application was filed on August 30, 2023.
Patent Application for Propagator Cells and Phage Propagation Methods
The USPTO has published a new patent application (US20260085296A1) detailing propagator cells and methods for propagating phage, particularly for delivering CRISPR-Cas components via probiotic organisms. The application was filed on December 4, 2025.
B.PINK Trademark Application Published for Opposition
The USPTO has published the trademark application for 'B.PINK' for opposition. This publication pertains to a wide range of digital and telecommunication services related to health management, fitness, nutrition, and well-being.
HT Hadat Cosmetics Trademark Publication
The USPTO has published the trademark application for HT Hadat Cosmetics for opposition. The application covers a broad range of services including import-export, commercial information, advertising, business auditing, and marketing services.
VPX Trademark Application Published for Opposition
The USPTO has published the trademark application for 'VPX' for medical and surgical instruments, apparatus, and implants, as well as medical and healthcare clinic services. The application was published for opposition on March 26, 2026, with a filing date of April 30, 2025.
MYHEALTHPRAC trademark published for opposition
The USPTO has published the trademark application for MYHEALTHPRAC, which covers software development for mobile applications and advisory services relating to healthcare. The application was published for opposition on March 26, 2026, following a filing date of February 26, 2025.
EYEQ trademark application published for opposition
The USPTO has published the trademark application for 'EYEQ' for opposition. The application covers a range of medical and psychological services, as well as related software and training. The publication date is March 26, 2026, with a filing date of July 30, 2024.
Proposed Rescission of LGBTQI+ Children Placement Requirements
The Administration for Children and Families (ACF) proposes to remove the 'Designated Placement Requirements Under Titles IV-E and IV-B for LGBTQI+ Children' rule. This action follows a court decision vacating the rule, which had required specific placement availability for LGBTQI+ children in foster care. ACF is seeking public comment on this proposed rescission.
SMILE+ DAILY ORAL DEFENSE Trademark Application
The USPTO has received an intent-to-use trademark application for 'SMILE+ DAILY ORAL DEFENSE' filed on March 25, 2026. The application covers dietary and nutritional supplements. This filing indicates a future intention to use the mark in commerce.
VERO Intent to Use Trademark Application Filed
The USPTO has received an intent-to-use trademark application for the mark 'VERO'. The application, filed on March 25, 2026, covers dietary and nutritional supplements, including satiety beverages and powdered drink mixes.
HANPO PATCH Trademark Application - Herbal Mud Packs
The USPTO has received an intent-to-use trademark application for 'HANPO PATCH' for goods including herbal mud packs, medicinal herbs, and dressings. The application was filed on March 25, 2026, with an intended use date of March 26, 2026.
AIX Trademark Application for Dental Services
The USPTO has received an intent-to-use trademark application for the mark AIX, filed by an unspecified applicant. The application covers a range of dental services and products, including denture fitting, oral surgery, dental implants, and custom prosthetics. The filing date for this application was March 25, 2026.
Fertility Centers of New England Registered Trademark
The USPTO has registered a trademark (TM78517534) for Fertility Centers of New England, covering medical services, laboratory, and research services. The trademark was registered on March 26, 2026, with a filing date of November 16, 2004.
AMALA Trademark Registration (TM77347849) - Medical Services
The USPTO has registered trademark TM77347849 for the mark AMALA, covering a range of medical, health care, and cosmetic services. The registration was finalized on March 26, 2026, following a filing date in December 2007.
AMA LA Trademark Registration - Educational and Health Services
The USPTO has registered trademark TM77473347 for AMA LA, covering educational services in cosmetics, health care, and essential oils, as well as consultation and health care services. The trademark was registered on March 26, 2026, with a filing date of May 13, 2008.
GCVS veterinary services trademark registered
The USPTO has registered the trademark GCVS GULF COAST VETERINARY SPECIALISTS for veterinary services, including dermatology, allergy, internal medicine, neurology, oncology, diagnostic imaging, surgery, and orthopedics. The registration is effective March 26, 2026.
AHEALTHYME Trademark Registration
The USPTO has registered the trademark AHEALTHYME (TM78491961) for services providing health information via an internet website. The registration was finalized on March 26, 2026, based on a filing date of September 30, 2004.
Rabid Skunks Confirmed in Pickens County; One Person and One Horse Exposed
The South Carolina Department of Public Health confirmed two skunks tested positive for rabies in Pickens County, leading to exposure for one person and one horse. The notice reminds residents of rabies vaccination requirements for pets and livestock.
MDHHS Seeks Applications for Victim Advocacy and Response Services Grant
The Michigan Department of Health and Human Services (MDHHS) is seeking applications for victim advocacy and system response services through the STOP Violence Against Women Formula Grants program. Approximately $1.763 million is available, with grant applications due May 1, 2026.
CMS Seeks Public Comment on Information Collection Activities
The Centers for Medicare & Medicaid Services (CMS) is seeking public comment on its intention to collect information, specifically regarding the State-based Exchange Annual Reporting Tool (SMART). This notice provides an opportunity for comment on the necessity, utility, and burden of the proposed information collection.
CMS Seeks Public Comment on Information Collection Activities
The Centers for Medicare & Medicaid Services (CMS) is seeking public comment on its intention to collect information from the public, as required by the Paperwork Reduction Act. This notice provides an opportunity for comment on the necessity, utility, and burden of proposed information collections, including those related to Qualified Health Plan (QHP) certification.
FDA Approves Kresladi, First Gene Therapy for Severe LAD-I
The FDA has approved Kresladi (marnetegragene autotemcel), the first gene therapy for severe Leukocyte Adhesion Deficiency Type I (LAD-I) in pediatric patients. This accelerated approval offers a new treatment option for a rare inherited immune deficiency, targeting the underlying genetic cause of the disease.
Patent Application: Cytotoxic Lymphocyte Activation and Expansion
The USPTO has published patent application US20260083776A1 concerning methods for activating and expanding cytotoxic lymphocytes with decreased exhaustion potential. The application details micropatterned surfaces and biofunctionalization techniques for cell expansion, potentially impacting future therapeutic development in oncology.
USPTO Patent Application for Compounds Targeting Pax3/Foxo1 Fusion Protein
The USPTO has published patent application US20260083724A1, filed by Georgetown University, for novel compounds designed to target the PAX3::FOXO1 fusion protein. These compounds aim to reduce protein levels and treat fusion-positive rhabdomyosarcoma.
Patent Application: Sigmari Ligand for Pancreatic Cancer Treatment
The USPTO has published a patent application (US20260083725A1) for a Sigmari Ligand for the treatment of pancreatic cancer. The application details a method involving a Sig-1R ligand to inhibit tumor growth and metastasis, filed on August 9, 2023.
Cancer Treatment Methods Using Tumor Treating Fields, Chemotherapy, and Anti-Fibrotic Agents
The USPTO has published a patent application detailing methods for treating cancer. The application describes compositions and systems involving the concurrent application of tumor treating fields, chemotherapeutic agents, and anti-fibrotic agents to reduce cancer cell viability and tumor growth.
Biopolymers for Ophthalmic Use Patent Application
The USPTO has published a patent application (US20260083771A1) for biopolymers intended for ophthalmic use, filed by ExoPolymer, Inc. The application details biopolymers comprising repeating polysaccharide units, their preparations, ophthalmic compositions, and methods of use.
Patent Application for Fiber-Based Prebiotic Dietary Supplements
The USPTO has published a patent application (US20260083772A1) for powder compositions comprising fiber intended for use as a prebiotic dietary supplement. The application details therapeutic ingredients and manufacturing processes aimed at improving gut microbiome and overall gut health.
Pegylated Menaquinol Compositions and Treatment Methods Patent Application
The USPTO has published a patent application (US20260083773A1) for pegylated menaquinol compositions and methods of treatment. The application, filed on December 5, 2025, discloses isolated, stable, and biologically active pegylated menaquinol derivatives for treating various diseases.
Patent Application: Acetic Acid and Hypochlorous Acid Compositions for Skin Trauma Treatment
The USPTO has published a new patent application (US20260083774A1) detailing compositions containing hypochlorous acid and acetic acid for treating skin trauma and biofilms. The application was filed on September 22, 2025, and published on March 26, 2026.
Metal nanoparticle agglomerates for infection control and water purification
The USPTO has published a patent application detailing the use of metal nanoparticle agglomerates for infection control and water purification. The application describes antiseptic substrates and fluid formulations incorporating these agglomerates for topical or oral use, aiming to provide infection control against infective agents.
Guidance on Post-Flood Cleanup and Health Safety
The Hawaiʻi Department of Health (DOH) has issued guidance for residents impacted by recent flooding. The guidance provides recommendations for safe cleanup procedures, mold prevention, and floodwater safety to protect public health during recovery efforts.
Therapeutic Agent for ALS Inhibits Ferroptosis Using Tetrahydroquinoline Derivative
The USPTO has published a patent application (US20260083723A1) from Toray Industries, Inc. The application describes a therapeutic or preventive agent for amyotrophic lateral sclerosis (ALS) that inhibits ferroptosis, utilizing a tetrahydroquinoline derivative as the active ingredient. This filing details compositions and methods for treating ALS and inhibiting ferroptosis.
USPTO Patent Application for Improving Sperm Quality
The USPTO has published a patent application (US20260083719A1) filed by The University of Adelaide for methods and products aimed at improving sperm quality. The application details the use of specific compounds, such as BGP-15, in assisted reproductive technologies.
Piperidine Urea Derivatives for Obesity Therapy Patent Application
The USPTO has published a patent application (US20260083718A1) filed by Astrizi Bio, Inc. The application describes piperidine urea derivatives for preventing, suppressing, or treating obesity, potentially in combination with GLP-1 receptor agonists.
Deuterated Domperidone Formulations for Gastroparesis and Nausea
The USPTO has published a patent application (US20260083717A1) for deuterated domperidone formulations. These formulations are intended for treating gastroparesis, nausea, vomiting, and other related conditions. The application details specific excipient combinations for these pharmaceutical compositions.
R-Trihexyphenidyl Patent for Movement Disorder Treatment
The USPTO has published a new patent application, US20260083716A1, filed by The Children's Mercy Hospital. The patent covers compositions and methods for treating movement disorders, such as dystonia, using high chiral purity R-trihexyphenidyl.
Immunity Enhancing Composition with Amide Compound
The USPTO has published a patent application (US20260083715A1) for a composition containing a novel amide-based compound derived from amino acids. The composition is designed to enhance immunity by activating macrophage phagocytosis, aiding in the removal of pathogenic bacteria.
Dosing regimen for treating PKU with piperidine inhibitor
The USPTO has published a new patent application (US20260083714A1) detailing a dosing regimen for treating phenylketonuria (PKU) using a piperidine inhibitor of SLC6A19 function. The application was filed on August 25, 2023, by inventors John Peter Throup and Heather Smith Blanchette.
Patent Application: Childhood Atropine Formulation for Myopia Progression
The USPTO has published a patent application (US20260083720A1) filed by Vyluma Inc. for a storage-stable, low-dose atropine formulation (0.01%) intended to reduce myopia progression in children. The application details the formulation's unexpected effectiveness compared to a higher concentration.
VIBRONIC Trademark Application for Medical Instruments
The USPTO has received a trademark application for the mark 'VIBRONIC' for use with medical instruments, including nebulizers, liquid inhalers, and aerosol dispensers. The application was filed on December 2, 2014, and is currently undergoing review.
VITALSCAN Trademark Registration for Blood Pressure Monitors
The USPTO has registered the VITALSCAN trademark for blood pressure monitors. The trademark covers devices suitable for self-administration and was filed on May 2, 2007, with registration effective March 25, 2026.
Fever Insight medical thermometer trademark registered
The USPTO has registered the trademark 'Fever Insight' for medical thermometers. The trademark application was filed on November 19, 2007, and officially registered on March 25, 2026. This registration pertains to thermometers for medical purposes.
EXACTEMP medical thermometers trademark registered
The USPTO has registered the trademark EXACTEMP for medical thermometers, including radiation, infrared, and ear thermometers. The registration was finalized on March 25, 2026, based on a filing date of September 15, 2003.
NEUROFAX Trademark Registration for Medical Instruments
The USPTO has registered the trademark NEUROFAX for medical instruments, specifically electroencephalographs. The trademark was registered on March 25, 2026, with a filing date of May 7, 1986.
Surgical instruments trademark registered: Thompson retractors
Surgical instruments trademark registered: Thompson retractors
HIZENTRA solution recalled due to appearance out of specification
Health Canada has issued a recall for the HIZENTRA solution due to an appearance out of specification in lot P100834477. The recall is classified as Type II, indicating a low risk to health. End users are advised to consult healthcare providers before discontinuing use.
Prosthetic Valve with Enhanced Sealing
The USPTO has published a patent application for a prosthetic valve with enhanced sealing for heart applications. The application details apparatuses, systems, and methods for prosthetic valves designed to improve sealing and engagement with the patient's heart structures.
Biological Patellar Groove Replacement Assembly Patent
The USPTO has published a new patent application, US20260083566A1, for a biological patellar groove replacement assembly and operation method. The patent, assigned to HEFEI LONGSHORE TECH CO., LTD, details a medical device designed to improve the accuracy and success rate of patellar implantation procedures.
Dry Cellulose-Reinforced Hydrogels for Implants
The USPTO has published a patent application (US20260083565A1) for dry cellulose-reinforced hydrogels designed for implants that rehydrate in situ. The application details a hydrogel implant that can be inserted into the body and allowed to rehydrate within the patient.
USPTO Patent for Glenoid Implant Components and Instruments
The USPTO has published a new patent application, US20260083564A1, for glenoid implant components and instruments. The patent, assigned to HOWMEDICA OSTEONICS CORP., details a glenosphere handling tool designed to assist in surgical procedures. This publication represents a new intellectual property filing within the medical device sector.
Medical Devices for Shunts, Occluders, Fenestrations and Related Systems
The USPTO has published a new patent application, US20260083563A1, detailing an implantable medical device for shunts, occluders, and fenestrations. The application describes a device with discrete frame components and a conduit portion with a membrane. This represents a new patent filing for a medical device technology.
Adjustable Interatrial Devices Control Heart Blood Flow
The USPTO has published a patent application for an adjustable interatrial device designed to control blood flow between the atria of a patient's heart. The application, filed by Brian Fahey and William Jason Fox, details a device that can be adjusted to open or close blood flow based on sensor readings.
Heart Valve Repair Devices Patent Application
The USPTO has published a new patent application (US20260083561A1) for heart valve repair devices and delivery systems. The application, filed on December 3, 2025, describes devices with force measurement capabilities for repairing native heart valves.
Patent Application for Annuloplasty Device Delivery and Securing
The USPTO has published a new patent application (US20260083560A1) for annuloplasty methods and devices, filed by Cinch Medical AS. The application details a system for delivering and securing intracorporeal devices, particularly for annuloplasty procedures.
Patent Application for Semi-Automated Crimper for Heart Valves
The USPTO has published a new patent application (US20260083559A1) for a semi-automated crimper system designed for balloon expandable heart valves. The application was filed by St. Jude Medical and details a system involving a delivery system, catheter, balloon, syringe, and a crimper with a collapsible iris assembly.
Prosthetic Suturing Device Application Published
The United States Patent and Trademark Office published a patent application for a prosthetic suturing device and methods thereof. The application, filed on December 1, 2025, details a cassette designed for use in such a device, including its base, cover, and needle components.
Prosthetic Heart Valve Assembly Method Patent Application
The USPTO has published a patent application (US20260083557A1) detailing a method for assembling a prosthetic heart valve. The application describes a specific technique for connecting leaflets to a frame and positioning them on the exterior of the frame.
Prosthetic Heart Valve Skirt Application
The USPTO has published a patent application (US20260083556A1) from Edwards Lifesciences Corporation for a prosthetic heart valve skirt. The application details a design featuring a frame with an inflow and outflow end and a skirt with specific fiber arrangements.
Prosthetic Heart Valve Outer Skirt Patent Application
The USPTO has published a patent application filed by Edwards Lifesciences Corporation for a prosthetic heart valve outer skirt. The application details a design incorporating both tissue and non-tissue layers to improve valve performance and durability.
Prosthetic Heart Valves with Expansion and Locking Assemblies Patent Application
The USPTO has published a patent application (US20260083554A1) from Edwards Lifesciences Corporation for prosthetic heart valves with expansion and locking assemblies. The application details mechanically expandable prosthetic devices and methods for changing their diameter.
Prosthetic heart valve with non-cylindrical frame application
The USPTO has published a patent application (US20260083553A1) for a prosthetic heart valve with a non-cylindrical frame, assigned to Edwards Lifesciences Corporation. The application details a specific design for the frame and valvular structure intended for implantable prosthetic devices.
US Patent Application for Implant Devices with Elastic Tubes
The USPTO has published a new patent application (US20260083552A1) from Edwards Lifesciences Corporation for implant devices featuring elastic tubes designed to enhance fluid vessel compliance. The application details anchoring structures and prosthetic valves for use in medical implants.
Sinus Stent System and Methods for Deployment
The USPTO has published a new patent application, US20260083550A1, for a sinus stent system and methods for deployment, assigned to Stryker European Operations Limited. The application details a stent made of flexible foam and film layers designed for deployment within a patient's frontal sinus.
Patent Application for Suture Construct Card Holder
The USPTO has published a patent application (US20260083549A1) for a card holder designed to organize suture constructs for surgical use. The application details a method for engaging and disengaging a suture construct from the holder, aiming to improve ease of use during surgery.
Felt Material for Repairing Human or Animal Soft Tissues
The USPTO has published a new patent application, US20260083548A1, filed by ZURIMED TECHNOLOGIES AG. The application describes a felt material designed for repairing or augmenting human or animal soft tissues, along with a set of instruments for its application.
Felt Material Patent for Soft Tissue Repair
The USPTO has published a new patent application (US20260083547A1) for a felt material designed for repairing or augmenting human or animal soft tissues. The application, filed by ZURIMED TECHNOLOGIES AG, details a felted patch and a set of instruments for its application.
Folded Stent Graft and Method of Manufacture Application
The USPTO has published a new patent application, US20260083546A1, detailing a folded stent graft and its method of manufacture. The application was filed on September 19, 2025, by inventors John Hall and Wayne Mower.
USPTO Patent Application for Aortic Disease Treatment Apparatus
The USPTO has published a new patent application (US20260083545A1) for an apparatus designed for the endovascular treatment of aortic diseases. The application, filed by Braile Biomédica Indústria Comércio e Representações Ltda., details a stent graft with both balloon-expandable and self-expanding sections for improved positioning and fixation.
Stent Graft with Low Profile Passive Sealing Skirt and Method
The USPTO has published a new patent application, US20260083544A1, detailing a stent graft with a low-profile passive sealing skirt and a method for its use. The application was filed on September 15, 2023, and describes an invention designed to improve sealing and packing density in delivery configurations.
Surgical Device for Pelvic Organ Prolapse Treatment
The USPTO has published a patent application (US20260083543A1) for a surgical device designed for treating pelvic organ prolapse, specifically uterine prolapse. The application was filed on November 2, 2022, and published on March 26, 2026.
System for Pre-Operative Planning of Total Joint Arthroplasty
The USPTO has published a patent application (US20260083509A1) for a system and method for pre-operative planning of total joint arthroplasty. The application, assigned to Smith & Nephew, Inc., details a tool that models joint movement and analyzes implant placement for surgical planning.
Patent Application for Cryogenic Blunt Dissection Methods and Devices
The USPTO has published a new patent application (US20260083491A1) filed by Pacira CryoTech, Inc. The application details methods and devices for cryogenic blunt dissection of tissue, specifically targeting the temporoparietal fascia layer for therapeutic effects on nerves. The filing date was December 3, 2025.
System for Sacroiliac Joint Fusion Surgical System Patent Application
The USPTO has published a patent application (US20260083489A1) for a surgical system designed for sacroiliac joint fusion. The application details a system comprising a sliding joint finder and a working cannula with specific protrusions for engaging the SI joint.
Patent Application: Non-invasive methods and devices to relieve dry eye symptoms
The USPTO has published a new patent application (US20260083633A1) for non-invasive methods and devices to relieve dry eye symptoms. The application, filed by Tianxin Wang, describes technologies that use breath or steam to provide moisture to the eyes or apply warm water streams to the eyelids.
Device for treatment of aneurysm patent application filed
The USPTO has published a patent application (US20260083347A1) for a device designed for treating aneurysms. The application, filed on October 21, 2025, describes an implantable member to be placed in connection with a blood vessel to exert pressure on an aneurysm.
Medical device with adjustable shaft length for stent delivery
The USPTO has published a new patent application (US20260083302A1) assigned to Boston Scientific Scimed, Inc. The application describes a medical device with an adjustable shaft length for stent delivery, aiming to improve usability with connectors and endoscope working channels.
Medical Device Patent Application - Rhenium-Chromium Alloy
The USPTO has published a patent application (US20260083875A1) for a medical device utilizing a rhenium-chromium alloy. The application was filed on November 26, 2025, by inventor Noah Roth. This represents a new potential innovation in the field of medical device materials.
USPTO Patent Application for Implant Communication System
The USPTO has published patent application US20260083397A1 for an implant communication system. The application, filed on September 24, 2024, describes an implant with sensors capable of communicating implant or surgical site data to an external source under specific conditions.
Flexible Thermal Device Patent Application
The USPTO has published a patent application (US20260083587A1) for a flexible thermal device. The application, filed on May 29, 2025, describes a device comprising an elastic fabric ring with gel cells retained in panels.
Prosthetic Socket Cooling System and Method Patented
The USPTO has published a patent application for a prosthetic socket cooling system and method assigned to Liberating Technologies, Inc. The patent, filed on May 2, 2025, describes a system designed to maintain a desired temperature within a prosthetic socket.
Oral retainer device for dysphagia treatment
The USPTO has published a new patent application (US20260083585A1) for an oral retainer device designed to treat dysphagia by limiting tongue movement during sleep. The application, filed by TONGUE LAB EUROPE LTD, details a method involving nightly wear of the device for 2-18 months and monitoring tongue strength.
Patent Application for Fluid Collection Assemblies
The USPTO has published patent application US20260083584A1 for fluid collection assemblies. The application details a design for a fluid impermeable barrier with a sump and base, intended for application to the pubic region of an individual.
Ostomy Apparatuses and Methods of Use Patent Application
The USPTO has published a new patent application (US20260083583A1) for ostomy apparatuses and methods of use, filed by Rodney Clingan and Robert Adams. The application details an apparatus designed to securely interface with a patient's stoma and couple an ostomy bag.
External Nasal Dilation Device Patent Application
The USPTO has published a patent application for an external nasal dilation device designed to enhance nasal airflow. The application, filed by Junkun Ma, details a device with pads that adhere to the sides of the nose and a flexible panel that expands the nostrils.
US Patent Application for Mechanical Crimper by St. Jude Medical
The USPTO has published a new patent application (US20260083579A1) for a mechanical crimper filed by St. Jude Medical. The application details a device designed for crimping medical devices, featuring an iris assembly and a sizing key mechanism to adjust the crimping size.
Medical Brace Patent Application
The USPTO has published a new patent application, US20260083581A1, filed by John Noel on September 25, 2025. The application describes a medical brace with opposing helix structures designed to conform to an object's contour. This is a routine publication of a patent application.
Stent Delivery System with Observation Device and Processors
The USPTO has published a new patent application by Olympus Corporation for a stent delivery system. The system incorporates an observation device and processors to acquire images and identify stent placement candidates.
Stent with flexible connecting elements
The USPTO has published a new patent application (US20260083577A1) for a stent with flexible connecting elements. The application details a stent design incorporating polymeric connecting elements that fold within the space between the stent's outer and inner diameters.
Transradial Prosthesis Assessment System Patent Application
The USPTO has published a patent application (US20260083576A1) for a transradial prosthesis assessment system. The application details an apparatus and method for simulating and evaluating the alignment and functionality of prosthetic systems for users. This is a routine publication of a new patent application.
Patent Application Filed for Knee Replacement Surgery Device
The USPTO has published a new patent application (US20260083575A1) for a knee alignment measurement tool designed for use during total knee replacement surgery. The application was filed on December 1, 2025, by inventor Jae S Son.
Patent Application: Free Hand Navigation Instruments for Total Hip Arthroplasty
The USPTO has published a new patent application (US20260083574A1) for free hand navigation instruments designed for total hip arthroplasty procedures. The application details methods for computer-navigation assisted surgery, including navigated instruments and tracking systems.
Surgical Systems for Percutaneous Bunion Correction
The USPTO has published a new patent application, US20260083573A1, filed by Fusion Orthopedics USA, LLC. The application describes surgical systems and methods for percutaneous bunion correction, including aligning guides and periscopes for screw placement.
USPTO Patent for Expandable Intervertebral Implant
The USPTO has published a new patent application, US20260083572A1, for an expandable intervertebral implant and bone graft delivery system. The patent was assigned to Spinal Surgical Strategies, Inc., d/b/a Kleiner Device Labs, and filed on August 18, 2025. This represents a new intellectual property filing in the medical device sector.
USPTO Patent Application for Expandable Spinal Implant
The USPTO has published a patent application (US20260083571A1) for an expandable and conforming spinal implant. The application details systems and methods for interbody implants designed to adapt to bony endplate topology.
Human Orthopaedic Surgery System and Implant Planning Method
The USPTO has published a new patent application (US20260083570A1) for a human orthopaedic surgery system and implant planning method filed by Lock-In VCF SA. The application details a system for planning surgery to restore bone volume and geometry using expandable bone implants.
Vertebral Implant System Patent Application
The USPTO has published a patent application for a vertebral implant system filed by FOUNDATION SURGICAL GROUP, INC. The application details a system comprising upper and lower staples and a vertical member, potentially a plate, designed for correcting vertebral body alignment and installation from various angles.
Patent Application for Custom Implant Design and Instrumentation
The USPTO has published a patent application (US20260083568A1) for a system and method for custom implant design and instrumentation. The application details a bone implant component with a patient-specific surface and instrumentation for preparing bone to receive the implant.
Joint Implant, Preoperative Planning, Arthroplasty Method Patent Application
The USPTO has published a new patent application, US20260083567A1, detailing a joint implant with an anchoring structure for improved positioning during arthroplasty. The application was filed by inventor Daniel Beer and includes classifications related to medical devices and surgical planning.
Ocular device with passthrough lens and electronic projection
The USPTO has published a new patent application, US20260083594A1, for an ocular device with a passthrough lens and electronic projection. The device is designed for implantation in the eye and features imaging and projection systems to display images on the retina, with adjustable vision modes and power minimization.
Malleable Earplug Attachment for Safety Glasses
The USPTO has published a patent application (US20260083593A1) for a malleable earplug attachment designed for safety glasses. The attachment includes an earplug, an elastic band, and a pocket to secure it to the temple ends of standard safety glasses.
Eye Shunt System and Methods Patent Application
The USPTO has published a new patent application, US20260083592A1, for an eye shunt system and methods. The application details a device designed to regulate intraocular pressure by receiving aqueous fluid from the eye and releasing it to the sclera.
System for Shaping and Implanting Biologic Intraocular Stent
The USPTO has published a new patent application (US20260083591A1) for a system designed to shape and implant a biologic intraocular stent. The application, filed on September 24, 2025, details a system including a delivery device and a nose cone assembly intended to lower intraocular pressure.
Ophthalmic Surgical Instrument Patent Application
The USPTO has published a patent application (US20260083590A1) for an ophthalmic surgical instrument designed for improved capsular bag safety and efficiency in phacoemulsification and irrigation/aspiration procedures. The application details specific tip designs with convexly curved side walls and flat bottom walls.
Device for Injecting Fluid into Eye Suprachoroidal Passage
The USPTO has published a new patent application (US20260083589A1) for a device designed to inject fluid into the suprachoroidal passage of an eye. The application, filed by Everads Therapy Ltd., describes a method for suprachoroidal buckling using a specialized needle and fluid composition.
Eye lubricant patent application US20260083588A1 by Meibomian Solutions LLC
Eye lubricant patent application US20260083588A1 by Meibomian Solutions LLC
Haptic Gloves for Enhanced Music Experience and Medical Applications
The USPTO has published a patent application (US20260083595A1) for haptic gloves designed to synchronize with iPhone haptic features for an enhanced music experience, particularly for the deaf or hard of hearing. The application also notes potential medical rehabilitation applications.
Tampon with wicking member and improved manufacturability patent application
The USPTO has published a new patent application (US20260083597A1) for a tampon with a wicking member and improved manufacturability. The application details an invention involving a non-coaxially arranged wicking member with respect to the withdrawal cord.
USPTO Patent Application for Absorbent Article Packages
The USPTO has published a new patent application (US20260083599A1) for absorbent article packages. The application, filed on September 17, 2025, describes a cuboidal package design with reclosable features for one or more absorbent articles.
Absorbent article with increased stiffness and elasticated flaps
The USPTO has published a patent application for an absorbent article with increased stiffness and elasticated flaps. The application, filed by inventors from an unspecified company, details a design intended to improve the structural integrity of absorbent products like diapers or incontinence pads.
Patent Application: Recycled Material in Flexible Packaging for Absorbent Articles
The USPTO has published a patent application (US20260083600A1) for a package containing absorbent articles made with recycled materials. The application details a multilayer plastic film with at least 50% recycled content and absorbent articles with at least 5% recycled content, aiming for an improved eco-factor.
Configurable Absorbent Articles Patent Application
The USPTO has published a patent application (US20260083601A1) for configurable absorbent articles featuring removable fastening members. The application details the inventors and the technical abstract describing the article's components, including a topsheet, backsheet, absorbent core, leg cuffs, and fastening members. The filing date was August 20, 2025.
Suture/Anchor and Delivery Device Combination Patent Application
The USPTO has published a new patent application (US20260083448A1) for a suture/anchor and delivery device combination. The application, filed on September 20, 2023, describes a device designed for interference fixation within bone using a novel suture assemblage and inserter.
Patent Application for Implant Compositions for Tendon Repair
The USPTO has published a new patent application (US20260083879A1) for implant compositions and methods for tendon and ligament repair. The application describes a composition of fibers and osteoinductive material to enhance bone formation and provide initial fixation for tendon to bone repair.
Nintedanib Formulations for Back-of-the-Eye Disease Treatment
The USPTO has published a patent application (US20260083727A1) detailing new formulations and intravitreal implants containing nintedanib for treating back-of-the-eye diseases. The application was filed on August 11, 2023.
Electronic Vision System Using Ocular and Neural Devices
The USPTO has published a new patent application, US20260083969A1, for an electronic vision system using ocular and neural devices. The application details a system designed to restore vision by stimulating the user's visual cortex.
USPTO Patent Application for Bioimplant Alloy
The USPTO has published patent application US20260085389A1 for a novel high entropy alloy developed by KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. The alloy is intended for bioimplant applications and is designed to offer improved corrosion resistance, anti-bacterial properties, and a reduced elastic modulus.
Patent Application: Compounds for Inhibiting IL-17
The USPTO has published a patent application (US20260083708A1) detailing compounds for inhibiting IL-17 activity. The application, filed on December 1, 2025, describes compounds and methods for treating inflammatory and autoimmune disorders.
Patent Application: Combination Pharmacological Interventions for Sleep Apnea
The USPTO has published patent application US20260083709A1, detailing a novel pharmacological intervention for treating obstructive sleep apnea. The application, filed on December 3, 2025, describes pharmaceutical compositions involving a combination of a norepinephrine reuptake inhibitor, muscarinic receptor antagonist, and carbonic anhydrase inhibitor.
USPTO Patent Application for Acute Migraine Treatment with Ubrogepant
The USPTO has published a new patent application (US20260083710A1) detailing methods for the acute treatment of migraine using the drug ubrogepant. The application includes specific claims related to treatment in patients with hepatic or renal impairment and those concurrently taking certain CYP3A4 modulators or BCRP/P-gp inhibitors.
Patent for treating ocular autoimmune disorder comorbidities with roflumilast
The USPTO has published a new patent application (US20260083712A1) assigned to Iolyx Therapeutics, Inc. The patent describes methods for treating ocular comorbidities of autoimmune disorders, such as dry eye disease, using ophthalmic formulations of roflumilast. The application was filed on September 19, 2025.
Multilayered Microparticles for Controlled Release of Active Compounds
The USPTO has published a new patent application (US20260083713A1) detailing multilayered microparticles for controlled release of active compounds in liquid dosage forms. The application was filed on October 21, 2025, by inventors from Belgium.
Tinostamustine for T-cell prolymphocytic leukemia treatment patent
The USPTO has published a patent application (US20260083707A1) for Purdue Pharma L.P. detailing the use of tinostamustine for treating T-cell prolymphocytic leukemia. The application was filed on July 28, 2025.
Patent Application: Methods for treating epilepsy using 5HT receptor agonists
The USPTO has published a new patent application (US20260083706A1) detailing methods for treating epilepsy using 5HT receptor agonists. The application was filed on May 29, 2025, by inventor Scott C. Baraban.
USPTO Patent Application for Transdermal Dexmedetomidine
The USPTO has published patent application US20260083705A1 for methods of using transdermal delivery patches containing dexmedetomidine to treat agitation. The application was filed on September 24, 2025, by inventors Wan-Ning Song and Gary G. Kay.
Novel LXR Modulators with Bicyclic Core for Treating Dyslipidemias
The USPTO has published a new patent application, US20260083704A1, detailing novel LXR modulators with a bicyclic core for treating dyslipidemias and related metabolic disorders. The application was filed on May 1, 2025, and published on March 26, 2026.
NY Health Launches Statewide Anti-Vaping Campaign for Youth
The New York State Department of Health has launched a statewide anti-vaping public awareness campaign targeting teens, young adults, and parents. The initiative, running through April 26, 2026, aims to educate on vaping risks and promote the 'DropTheVape' text support program for quitting nicotine products.
NY Landmarks Lit Purple for International Epilepsy Day
The New York State Department of Health announced that 16 state landmarks were lit purple on March 26, 2026, for International Epilepsy Day. This initiative honors the estimated 215,000 New Yorkers living with epilepsy and raises awareness for the condition.